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Abstract 
Purpose and Rationale: This project is designed to translate the collective knowledge and 
evidence-based interventions surrounding the reduction of central line-associated bloodstream 
infections (CLABSIs) and use these evidence-based practices to create an extracorporeal 
membrane oxygenation (ECMO) cannula site bundle. The desired outcome of creating an ECMO 
cannula-site bundle is increased cannula site integrity, decreased frequency of dressing changes, 
and minimized risk of cannula-site infections. 
 
Synthesis of Evidence: Currently, there are no clinical practice guidelines for ECMO cannula 
site care to guide bedside practice. The ELSO Infectious Disease Taskforce recommends 
implementation of a CLABSI bundle for ECMO site care, but many of the products used for 
CLABSI prevention are not intended for large ECMO cannula sites.   
 
Practice Change and Implementation Strategies:  The DNP students will create an ECMO 
cannula site bundle inspired by the CLABSI evidence available, as there is currently no ECMO 
specific products available. 
 
Evaluation:  To evaluate project success, the DNP students will investigate the number of 
dressing changes required for ECMO insertion sites due to saturated and/or not intact dressings 
comparing pre and post implementation cohorts.  
 
Conclusion and Implications for Practice: This project would serve as a mean to standardize 
approaches to dressing the ECMO cannula insertion site, and potential serve as a clinical practice 
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                                                                        Introduction 
Extracorporeal membrane oxygenation (ECMO) programs have grown in number 
internationally.  The Extracorporeal Life Support Organization (ELSO) is a consortium of 
ECMO centers worldwide that registers ECMO-related data and offers clinical guidance for the 
ECMO population.  According to ELSO, in 2010 there were 183 ECMO registered centers 
totaling 3,445 patients receiving ECMO therapy.  In 2019, there were 463 registered ECMO 
registered centers caring for nearly 16,000 ECMO patients (ELSO, 2020).  Despite this 4-fold 
increase in ECMO patients worldwide over the last decade, there has been minimal evidence 
published to guide the nurse in ECMO-related cares, particularly maintaining the integrity of the 
cannula insertion site dressing and preventing cannula related infections (CRI).  Currently, there 
are no clinical practice guidelines addressing ECMO cannula site care practices, the frequency of 
dressing changes, or appropriate dressings.  ELSO recommends that all cannula insertion sites 
are managed the same as any central line, and to implement hospital-based central line policy for 
cannula site care (ELSO Infectious Disease Task Force, 2019).  
A lack of clinical practice guidelines to support the bedside nurse results in a wide 
variation in practice to clean and dress the cannula insertion site.  This discontinuity in procedure 
and lack of policy to encourage best practice causes challenges in determining the most effective 
strategies for anchoring and dressing the ECMO cannula site.  This literature review will 
investigate the best suited materials for adequately dressing and anchoring ECMO cannula 
insertion sites by analyzing central line associated bloodstream infections (CLABSI) data and 
clinical practice guidelines and investigating the limited data on CRI prevention methods. 
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ECMO Cannulation Approaches and Oxygenation Methods 
There are two modalities for ECMO: venovenous (VV) and venoarterial (VA).  VA 
ECMO supports the heart and lungs of the patient by draining from a large vein and returning 
richly oxygenated blood into a large artery.  VA ECMO allows for the patient with a severely 
decreased ejection fraction to circulate oxygen-rich blood without the assistance of the heart.  
VA ECMO patients are most typically cannulated in the following sites: bifemoral sites, a 
singular femoral site, and central cannulation.  Bifemoral cannulation consists of a venous 
cannular in one femoral site, and the arterial cannula in the opposing femoral site.  A singular 
femoral site has the venous and arterial cannula in one femoral site.  Central cannulation requires 
surgical placement and is most used in the open-heart surgical patient population.  In central 
cannulation, the drainage cannula is in the right atrium, and the return cannula is placed directly 
in the aortic arch (ELSO, 2020). 
VV ECMO provides support to the lungs only.  In this ECMO population, the patient’s 
heart must be functioning adequately to meet their oxygenation needs.  The drainage cannula is 
place in a large vein, and the return cannula delivers oxygen-rich blood back into a large vein.  
This patient population has three methods for cannulation: North-South cannulation, bifemoral 
sites, a singular femoral site, and dual lumen cannulation.  North-South cannulation consists of a 
single cannula in the right internal jugular vein, and a single cannula in either the right or left 
femoral vein.  Dual lumen cannulas have both a drainage and return cannula forming a single 
cannula and are placed in the patient’s right internal jugular vein (ELSO, 2020). 
Peripheral cannulation is defined as either VA or VV ECMO cannulation that is placed in 
the femoral or internal jugular sites.  Central cannulation refers to VA ECMO that requires a 
sternotomy for placement.  Central cannulas need a specific dressing that is applied in the 
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operating room.   Dual lumen cannulas include both arterial and venous flow in a singular 
cannula with two lumens.  These cannulas are not frequently used at the facility of interest.  This 
project will focus on peripherally cannulated patients without dual-lumen cannulas, and therefore 
exclude all centrally cannulated patients and patients with dual lumen cannulas.    
 
PICO Question 
 A clinical question was developed in the Population (P), Intervention (I), Comparison 
(C), Outcome (O) (PICO) format. The clinical question to guide the literature review is as 
follows: In adult patients receiving venous-venous (VV) or venous-arterial (VA) ECMO therapy 
via bifemoral or single-lumen internal jugular with singular femoral (North-South) access points, 
does the implementation of a cannula dressing bundle including sterile dressing procedures and 
anchoring methods decrease the frequency of required dressing changes due to insertion site 
bleeding and/or loss of dressing integrity? 
The purpose of the proposed project aims to generate an evidence-based bundle for 
ECMO cannula site care inspired by data related to CLABSI bundle implementation, types of 
dressings utilized, and anchoring devices.  The selection of supplies utilized for ECMO cannula 
site care will be based on a thorough literature review to determine the best-suited supplies to 
sterilely care for an ECMO cannula insertion site as well as methods to determine and monitor 
dressing integrity and saturation of dressings.  CRI will be a secondary outcome and measurable 
through the presence, or absence, of CRIs within our respective patient population through the 
duration of this project.  CRI parameter suggestions are discussed below. 
 
Project Term Definitions. 
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In order to mitigate confusion, the National Healthcare Safety Network (2020) created by 
the Center for Disease Control and Prevention (CDC) was referenced for the appropriate 
terminology used to define the standard terms commonly utilized throughout the project and 
listed below: 
• Central line-associated bloodstream infection (CLABSI):  refers to a positive 
bloodstream infection in a patient with only a central line and no ECMO cannulas. 
• Bloodstream infection (BSI):  refers to a positive infection in the bloodstream that 
is not secondary to any other body site. For the purpose of this paper, BSI will 
describe a positive blood culture that is unable to be linked to either the ECMO 
cannula or the central line in a patient that is receiving ECMO therapy. 
• Cannula-related infection (CRI):  refers to a positive BSI while a patient is on 
ECMO. 
• Cannula site care bundle:  may be used interchangeably with the "cannula care 
bundle."  This wording refers to the sterile dressing process for the ECMO 
cannula insertion site, as well as the anchoring method for the cannula. 
 
Differentiating CRI from CLABSI in the ECMO population is challenging because there 
is not a known method for identifying whether a BSI was caused by an ECMO cannula or an 
invasive line.  There are currently no ELSO endorsed parameters or guidelines available to 
distinguish if a central line or an ECMO cannula is the primary cause for a positive BSI during a 
patient’s ECMO therapy. For this reason, the CDC currently does not track bloodstream 
infections that occur while a patient is on ECMO due to the challenges of differentiating a CRI 
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Literature Search Strategy 
Search Method.   
A literature search was completed by utilizing the research databases PubMed, CINAHL, 
ProQuest, and the review database Cochrane Library by using the search parameters listed in 
Appendix B. An internet search performed using Google provided direction to the CDC website 
where the clinical practice guideline for CLABSI were located.  Other valuable research 
documents were discovered from trials conducted by the CDC and their corresponding articles 
related to the CDC’s research. From these searches, articles were chosen based on their relevance 
to the chosen key terms and combed through for the quality of evidence, study design, sample 
size, study setting, and patient population.  
 
Selection Criteria.  
The literature search was separated into two separate themes: ECMO cannula infections 
and CLABSI rates. The search parameters for CLABSI rates and ECMO articles were focused 
on the adult intensive care unit (ICU) patient population published between 2010 to 2020 and 
published in the English language or translated to English. After the initial database search, the 
review was expanded to include the differences in CLABSI rates when using chlorhexidine 
gluconate (CHG), or medication-impregnated dressings or discs. By expanding the search with 
ECMO CANNULA CARE BUNDLE  10 
 
   
 
these terms, any non-suture securement devices were included to determine the difference 
between the various items commonly utilized for central line securement and CLABSI 
prevention. Lastly, studies on CLABSI-bundles were included, as well as differences in infection 
rates related to different insertion sites for central venous catheters. 
ECMO articles included in the literature review were those that discussed CRI and either 
identified ECMO patient risk factors for CRI, discussed dressing and cannula site care methods, 
and/or defined parameters used to define CRI.  Studies that surveyed cannula site care 
experiences at facilities providing ECMO therapies were also included.  ECMO surveys 
conducted for research purposes investigated data regarding ECMO cannula site care, dressing 




For the final literature review, 19 articles were included based on research over the topics 
of ECMO cannula securement, ECMO CRI, CLABSI rates related to central line location, and 
CLABSI rates. These articles were analyzed to determine their relation to central line 
securement, and CLABSI bundle procedures and how the interventions lowered rates of 
CLABSIs post-implementation compared to pre-implementation. Inclusion criteria consisted of 
confirmation of the study's intervention based on a statistical significance, relevance on the 
subject matter related to the proposed Doctor of Nursing Practice (DNP) project, and quality of 
evidence related to the type of study that would be accepted for due diligence the literature 
review. Studies with data that were not statistically significant were included in the literature 
review as these studies were of clinical significance and provided pertinent data on ineffective 
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methods for site care, allowing for the project to be adjusted as appropriate. A comprehensive 
table of included and excluded studies is available in Appendix A.   
 
Description of Studies. 
For the studies included in the literature review, eleven articles involved patients on 
ECMO. To further break down the research, the subject matter of four studies are related to 
securement methods used to safely prevent dislodgement of micro-shifts of the ECMO cannula 
(Bull, Corley, Lye, Spooner, & Fraser, 2019; Bull, Corley, Smyth, McMillan, Dunster, & Fraser, 
2018; Spencer, 2018; Tignanelli Weinberg, & Napolitano, 2019) and seven articles are directly 
related to infection risk, prevalence, and BSI prevention in ECMO patients (Allou et al., 2019; 
Aubron et al., 2013; Biffi et al., 2017; Corley et al., 2019; Hahne et al., 2015; Silvetti et al., 
2019; Vogel, Lew, Kao, & Lally, 2011).  Of the articles related to central venous catheters 
(CVC), five articles addressed research on CLABSIs, specifically. One article compared the 
difference in rates of infection for specific insertion sites (Marik, Flemmer, & Harrison, 2012), 
two articles focused on using antimicrobial dressings, aseptic dressing methods, and products for 
CLABSI prevention (Webster et al., 2017; Yu et al., 2019), two articles focused on comparing 
processes used to simplify regular CVC dressing changes (CLABSI bundles) and the effects 
these various processes have on CLABSI rates (Grigonis et al., 2016; Wichmann et al., 2018). 
Three additional articles were found outlining research that surrounds the safe securement of 
CVCs (Mitchell et al., 2019; Ullman et al., 2015) and one article investigated the relationship 
between proper securement of CVCs and CLABSI rates (Timsit et al., 2012).   
By adhering to the guidelines for inclusion, the goal was to strive to focus on articles that 
fulfilled the prerequired level of evidence determined by Melnyk and Fineout-Overholt’s 
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Evidence-Based Practice in Nursing and Healthcare (2019). By thoroughly examining all articles 
for validity, reliability, and applicability to the patient population, sixteen of the twenty-one 
articles referenced come from qualitative studies within levels I-IV, and four studies referenced 
include qualitative articles within levels V-VII. A summary of each article can be found in the 
literature review table in Appendix C.  
Figure 1 
Levels of Evidence 




I – Systematic Review/ 
Meta-analysis of Randomized Controlled Trials 
 
2 
Marik et al., 2012;  
Ullman et al., 2019 
II – Single Randomized Controlled Trials 
 
4 
Mitchell et al., 2019;  
Timsit et al., 2012;  
Webster et al., 2017;  
Yu et al., 2019 
III – Quasi-Experimental Studies/ 
Nonrandomized Controlled Trials 
 
2 
Bull et al., 2018;  
Hahne et al., 2015;  
IV – Cohort or Case-Controlled Studies 
 
9 
Allou et al., 2019;  
Aubron et al., 2013;  
Corley et al., 2019;  
Glater-Welt et al., 2016; 
Grigonis et al., 2016: 
Schmidt et al., 2012;  
Silvetti et al., 2019;  
Vogel et al., 2011; 
Wichmann et al., 2018;  
 
V – Systematic Review/ 
Meta-analysis of Qualitative Studies 
 
1 Biffi et al., 2017; 
VI – Single Qualitative or Descriptive Studies/ 
Evidence Implementation and Quality 
Improvement Projects 
 
1 Bull et al., 2019;  
VII – Expert Opinion 2 
Spencer, 2018;  
Tignanelli et al., 2019 
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Population and Setting. 
 The sample population within the articles of our literature table is isolated to the adult 
inpatient population. The setting for the articles referenced is predominately within the intensive 
care unit, apart from the article by Grigonis et al. which was conducted within a long-term acute 
care hospital setting. 
 
Excluded Studies 
Seven articles were reviewed and excluded from the literature review.  Although the 
articles contained data related to the search criteria provided above, these seven articles failed to 
provide specific interventions to ECMO cannula site care, or the CLABSI intervention being 
reviewed was not translatable to the ECMO cannula site.  Therefore, these seven articles were 
not considered in the final literature review process. 
 
Review of Evidence 
 
CLABSI Prevention 
The articles by Mitchell et al. (2019), Ullman et al. (2015), and Webster et al. (2017) 
indicate that the type of dressing utilized, Chlorhexidine gluconate (CHG) or silver-impregnated 
dressing, both reduced rates of CLABSI by having a CHG, or silver-impregnated disc present 
under the transparent dressing. According to the meta-analysis of randomized-controlled trials 
conducted by Ullman et al., the rate of infection reduced from 30 infections per 1000 catheter 
days to 19 infections per 1000 (RR 0.65, 95% CI 0.40-1.05) infection days when a CHG-
impregnated dressing was used to cover a CVC versus a standard polyurethane (SPU) dressing.  
ECMO CANNULA CARE BUNDLE  14 
 
   
 
Also, in the same study, CLABSIs were reduced from 28 infections per 1000 catheter days to 17 
(RR 0.60, 95% CI 0.39-0.93) infections per 1000 catheter days when a silver-impregnated 
dressing is utilized, versus an SPU dressing to cover a CVC. (2015, pp.5-6) 
Timsit et al. (2012) found that an increased frequency of dressing disruptions was directly 
related to an increased risk of microbial colonization beneath the CVC dressing. Researchers 
tested two patient groups with CVCs to determine the likelihood of microbial colonization by 
allocating one patient group to a scheduled 3-day dressing change cohort and the next patient 
group to a 7-day cohort, respectively.  It was established that multiple statistically significant 
variables existed that explained the disruption of CVC dressings. For example, patients being in 
a comatose state, an increased Sequential Organ Failure Assessment (SOFA) score, which 
indicates a higher level of organ failure, and an increased Simplified Acute Physiology Score II 
(SAPS II) which is an estimator of mortality in patients all impact the integrity of CVC dressings 
in the ICU setting. The researchers concluded that each dressing removal increased the risk for 
events such as, catheter colonization from the first dressing removal (p= 0.16, HR= 1.30, 95% CI 
0.90-1.87) compared to the final dressing removal (p <0.0001, HR=13.99, 95% CI 9.88-19.82), 
CLABSI first dressing removal (p= 0.17, HR=2.65, 95% CI 0.67-10.56) compared to the final 
dressing removal (p <0.0001, HR=18.11, 95% CI 5.66-57.88), and other major catheter-related 
infections from the first dressing removal (p= 0.33, HR=1.94, 95% CI 0.50-7.48) compared to 
the final dressing removal (p <0.0001, HR=12.51, 95% CI 3.95-39.62). The researchers 
calculated that all three microbial categories (catheter colonization, CLABSI, and other major 
catheter-related infections) increased the calculated hazard ratio for each category with each 
dressing removal. The articles by Grigonis et al. (2016) and Wichman et al. (2018) address the 
efficacy of dressing bundles towards decreasing the rates of CLABSIs within their respective 
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patient populations.  Wichman et al. examined the addition of a checklist to the existing CLABSI 
bundle to increase adherence and effectiveness to the bundled steps (2018). The researchers’ 
believed that, by creating a bundle checklist, they would create an additional tool to improve the 
effectiveness of the preexisting bundles and further reduce the frequency of CLABSIs within the 
ICU patient population. The rate of CLABSI infection in the pre-experimental observational 
group was 5.9 infections per 1000 catheter days and reduced to 3.8 infections per 1000 catheter 
days with the addition of the CLABSI checklist (Wichman et al., 2018, p.3).  The article by 
Grigonis et al. (2016) addresses the decrease in CLABSI infections when establishing a bundle 
program in a long-term acute care hospital (LTACH). The group evaluated the rates of CLABSI 
infection 14-months pre-bundle and 14-months post-bundle initiation.  The CLABSI-bundle that 
the researchers implemented at an LTACH included education on the CLABSI-bundle protocol 
to all staff members responsible for using CVCs, the mandatory use of alcohol-based central 
catheter caps, CHG dressings, and the formation of a CVC-nursing team to maintain all CVCs 
and demonstrate annual competency. The implementation of a CLABSI bundled program 
decreased the rate of CLABSI standardized infection ratio (SIR) as defined by the CDC from 
1.28 infections per 1000 catheter days to 0.96 infections per 1000 catheter-days (2016, p. 169). 
 
CLABSI Clinical practice guidelines.   
The CDC developed a guideline to prevent intravascular catheter-related infections in 
2011 and updated recommendations in 2017.  The CLABSI clinical practice guideline 
recommends the following for central line catheter care (CDC, 2017): 
•  Sterile gauze, transparent, or semi-permeable dressings should cover the catheter site.    
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• Sterile gauze is recommended if the patient is diaphoretic or the insertion site is oozing, 
followed by an alternative dressing once the oozing or sweating is resolved.  
• Antibiotic creams and ointments are not recommended.  
•  If a non-occlusive dressing or hemostatic dressing is used, the dressing should be 
changed every two days. 
• The occlusive dressing should be changed every seven days unless the patient is at high 
risk for catheter dislodgement or the dressing becomes compromised before the change 
date  
• Chlorhexidine-impregnated dressings or discs are recommended for patients aged 18 
years and older.  All dressings need to be cleared by the Food and Drug Administration 
(FDA) and have a specific clinical indication to reduce CLABSI. 
• Daily 2% chlorhexidine skin cleansing of the full body is recommended for all patients 
with central venous catheters. 
• Sutureless securement devices are recommended. 
Utilizing the Appraisal of Guidelines for Research and Evaluation (AGREE II) 
 instrument, this specific clinical practice guideline was found to be of high quality.   
The CDC’s central line guideline (2017) was reviewed and rated by the both authors 
using the AGREE II tool (2013). When analyzing the results organized in Appendix D, it is 
evident that this guideline meets the AGREE II high standards with an overall percentage of 
88.4%.  Both reviewers recommend the clinical practice guideline, but with modifications due to 
the continually evolving nature of CLABSI guidelines since the current guideline was last 
updated in 2017.  Please refer to Appendix E for a detailed AGREE II scoresheet. 
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 ECMO cannulation sites represented 
Peripherally cannulated VA and VV ECMO were well represented throughout the 
literature reviewed in 10 out of the 11 of the ECMO-related content.  Centrally cannulated VA 
ECMO was also well represented within the literature, but this is viewed as a surgical 
intervention requiring a cardiothoracic surgeon.  Due to the unique dressing and antibiotic 
requirements of this population, data related to centrally cannulated ECMO patients was not 
considered to be in the scope of the proposed project.  Articles related to central cannulation data 
were reviewed if the researchers were simultaneously investigating peripheral cannulation. 
 
Cannula-related infection  
The rate of BSIs in patients on ECMO ranged from 16 to 24.7 BSI days per 1,000 ECMO 
days (Allou et al., 2019; Aubron et al., 2013; Biffi et al., 2017; Silvetti et al., 2019; Schmidt et 
al., 2012).  According to the CDC's 2018 Hospital Acquired Infections Progress Report (2019), 
the calculated CLABSI infections for the State of Minnesota calculates to 0.8664 CLABSIs per 
1000 catheter days and Nationally as 0.9499 CLABSIs per 1000 catheter days.  There is a 
significantly higher incidence of BSI in the ECMO population compared to national rates for 
CLABSI, highlighting a need for practice change, further investigation of risk factors associated 
with CRI, and national CRI monitoring parameters.   
Hahne et al. (2015) sought to clarify criteria for CRI by culturing the end of the ECMO 
cannula immediately after decannulation.  The researchers found that 15.9% of the cannulas 
cultured in the study were positive for colonization.  Commonly colonized organisms identified 
by ELSO include Coagulase-negative staphylococci, Candida species, and pseudomonas (ELSO 
Infectious Disease Task Force, 2019).  The sole statistically significant risk factor for positive 
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CRI identified by Hahne et al. (2015) was positive blood culture during the ECMO run (p = 
0.010).  The patients who had positive blood cultures during ECMO therapy were at 4.762-time 
higher odds for the development of positive cannula colonization, indicating a positive CRI.  
Although the sample size for this article of 96 patients was rather small, this is the only article 
known to the writers in which the cannula tip underwent microbial analysis to determine if the 
ECMO cannulas were the cause for the BSI.  The challenge of this method for determining CRI, 
is the ECMO therapy must be discontinued to obtain a culture on the ECMO cannula tip, which 
may endanger the patient’s life.     
Five articles sought to define CRI by creating a timeline post-cannulation (initiation of 
ECMO) and post-decannulation (discontinuation of ECMO) in which a positive BSI would be 
attributed to the ECMO cannulas (Allou et al., 2019; Aubron et al., 2013; Corley et al., 2019; 
Schmidt et al., 2012; Silvetti et al., 2019).  Three of these five articles defined a positive CRI as a 
BSI that occurred 48 hours after the patient was initiated on ECMO (Allou et al., 2019; Aubron 
et al., 2013; Silvetti et al., 2019).  Two articles defined the ECMO insertion site as a surgical site. 
The studies by Allou et al., (2019) and Corley et al., (2019) both determined all patients that 
were on ECMO support that had a positive blood culture for up to 30 days after decannulation 
met parameters for CRI.  Silvetti et al. (2019) included post-cardiotomy patients on ECMO with 
positive BSI for 48-hours after decannulation, while Aubron et al. (2013) included ECMO 
patients up to 72 hours post decannulation as positive for BSI.  Schmidt et al. included all VA 
ECMO patients (including post-cardiotomy) who had a positive BSI 24 hours post cannulation 
and 48 hours post decannulation (2012).    
The criteria for CRI by Aubron et al. (2013), was created by using the CLABSI 
surveillance guidelines by the CDC from 2008.  Two articles defined peripheral cannula sites as 
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surgical sites and therefore utilized the CDC definition for a surgical site infection defined by the 
CDC (Allou et al., 2019; Corley et al., 2019).  CLABSI criteria were utilized for CRI criteria in 
the Schmidt et al. article (2012); however, the year that the criteria originate is not specified.  
 
Cannula anchoring   
In vitro porcine skin samples were cannulated and secured using different methods for 
sutureless cannula securement in the article by Bull et al. (2019). The study consisted of cohorts 
with six individual 21 French cannulations in pigskin with an adhesive dressing at the insertion 
site in addition to one of the following securement methods:  Dermabond, Grip-Lok Universal 
securement device, MultiFix Unifix universal tube and catheter securement, and Tensoplast 
elastic adhesive bandage.  It was found that Dermabond required the highest amount of force to 
dislodge the cannula (p < 0.0001).  Unfortunately, to remove Dermabond acetone must be 
applied.  After applying acetone to the cannula, there was noted to be a significant degradation to 
the tubing.  The Grip-Lok and MultiFix required a significantly higher force for dislodgement 
when compared to the Tensoplast tape (p < 0.01).  This is the only study known that investigated 
the effectiveness of specific anchoring devices with ECMO cannulas 
An article by Tiganelli, Weinberg, & Napolitano (2019) provides an expert opinion on 
securement methods for internal jugular (IJ) cannulas.  This cannula location has proven to be 
challenging to secure due to the proximity to the patient's face, providing no points for adequate 
anchoring.  The authors of this article shared their experiences using Coban to make a headband 
around the patients' heads to prevent cannula migration, which proved problematic when the 
adhesive's capability was lost.  The opaque- nature of Coban causes difficulty in assessing the 
skin beneath the wrap.  Tignanelli et al. shared that their facility uses Hold-N-Place leg bands, 
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which initially intended for Foley catheter securement.  This method is preferred to the Coban 
for IJ cannulas as it allows for better assessment of the skin, and patients seemed to find it more 
comfortable (Tiganelli et al., 2019).  The patients' comfort was not statistically analyzed, and this 
information was based on the opinion of the writers' expert opinion.  
 
ELSO surveys.   
Bull, Corley, Lye, Spooner, & Fraser (2019) surveyed 396 ELSO registered ECMO 
coordinators and directors investigating different methods for securing and dressing peripherally 
inserted cannulas.  Researchers received 391 individual responses from 45 different countries 
(46% of respondents were from the United States), 76% of respondents reported having a written 
guideline or policy for ECMO cannula dressing management, and 78% of respondents believed 
"that an international evidence-based guideline for ECMO line management would be beneficial 
to inform or improve bedside practices" (Bull et al., 2019, p. 7).  Cannula dislodgement, 
migration, and accidental decannulation in the last five years have been reported to have 
occurred at 34% of the responding facilities.  The respondents indicated what was believed to be 
the cause of the critical event, and inadequate cannula securement methods were sited to be the 
primary cause accounting for 28% of reported dislodgement events (Bull et al., 2019). 
Interestingly, Bulle et al. shared that other causes for reported cannula dislodgements 
occurred when a patient removed a cannula (12%), during turning or bathing of a patient (11%), 
and transport of a patient (4.2%).  These events could all arguably be related to inadequate 
securement techniques.  The specific cause for cannula dislodgment was not specified in 25% of 
the reported events (Bull et al., 2019).  There is a concern of under-reporting of this adverse 
event as providing detail was an optional response in the survey.   
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A survey of members of the ELSO registry regarding ECMO insertion and maintenance 
of cannulas, antibacterial prophylaxis, and infection surveillance was conducted by Glater-Welt, 
Schneider, Zinger, Rosen, & Sweberg (2016).  This survey was sent to ECMO directors and 
coordinators at 152 facilities based in the United States, 85 institutions participated.  A 
standardized facility-based approach to cannula dressings was reported by 82.9% of the surveyed 
facilities. Semi-permeable transparent dressings were used in 57.3% of respondents.  Glater-Welt 
et al. highlight a large variability in infection prevention practices and state that there is a need to 
standardize the bedside approach to cannula care (2016).   
A third ELSO survey by Vogel, Lew, Kao, & Lally analyzed potentially modifiable risk 
factors for infectious complications during ECMO support utilizing the ELSO registry data from 
1987 to 2009, including 2,996 adult ECMO runs as well as data on pediatric ECMO runs.  An 
infectious complication was loosely defined without clear rationale as the presence of a new 
organism while on ECMO or a white blood cell count below 1500.  Risk factors for infectious 
complications were found to be ECMO therapy lasting > 10 days (OR= 1.09, p < 0.001), the 
adult population (O 2.24, p < 0.001), and positive blood culture prior to the initiation of ECMO 
(OR= 2.49, p < 0.001). 
  
ECMO community outreach.   
The project leaders have become registered members of ELSO since the preliminary 
stages of the DNP project.  Using the ELSO directory for ECMO coordinators in the United 
States, the DNP students drafted an e-mail to informally survey dressing practices at various 
ECMO centers.  Of the 14 randomly selected ECMO coordinators contacted, 5 ECMO 
coordinators responded, offering information on practices at their centers.  Variance in ECMO 
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cannula site care practices was found across the responses received with a summation of the 
practices being: 
• Utilization of sutures for ECMO cannula stabilization is the most common 
practice across the polled ECMO centers. 
• A CHG-based scrub was used to cleanse the skin consistently on all patients. 
• The BioPatch brand of CHG-impregnated disc was utilized for CRI-prevention 
for those sites that used CHG-impregnated discs. 
• ECMO site dressing changes were not consistently changed at regular intervals 
• ECMO site dressing was consistently changed if bloody. 
• No ECMO center indicated having any ECMO dressing change protocol to 
standardize their practice. 
 
Cochrane reviews.   
A critical appraisal of a systematic review for dressings and securement of central venous 
catheters by Ullman et al. (2019) can be found in Appendix F.  The systematic review looked at 
21 different articles to compare available dressing and securement devices in order to identify the 
best dressing regimen to prevent CLABSI.  The population included short- and long-term CVCs, 
consisting of both tunneled and non-tunneled CVCs, internal port-a-caths, hemodialysis lines, 
and peripherally inserted central catheters in patients of any age.  The dressings reviewed 
included standard polyurethane, chlorhexidine impregnated, silver nitrate impregnated, sterile 
gauze, and the utilization of anchoring methods.  In summary, the reviewers stated that “there 
was inadequate research to permit us to make recommendations about CVC security using the 
different dressing and securement products” (Ullman et al., p. 32, 2019).  The large variety of 
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marketed dressings is a weakness in this review; reviewers were unable to pinpoint one superior 
dressing method.  Despite this, the reviewers did consistently find a decrease in CLABSI rates at 
facilities that utilizes chlorhexidine impregnated dressings and discs. 
An appraisal of a systematic review of the risk of catheter-related bloodstream infections 
(CRBIs) of femoral CVCs compared to the subclavian and internal jugular venous placement of 
CVCs by Marik et al. (2012) can be found in Appendix G. The meta-analysis reviewed two 
RCTs and eight cohort studies to evaluate for any increased prevalence of CRBI rate depending 
on femoral venous placement over subclavian and internal jugular placement. The study 
population was isolated to the adult patient population with non-tunneled CVCs and examined 
the difference that anatomical placement may have on risk for infection for CVCs. The 
researchers did not discuss what role the type and quality of external dressing played in the 
infection rates of their CVCs. In summary, the researchers evaluated that the data favored 
placement in the internal jugular vein as the lowest risk for CRBI, when compared to femoral 
placement (p= 0.005, RR= 1.90, 95% CI 1.21-2.97)  but concluded that there was no higher risk 
for infection for femoral-placed CVCs when compared to a subclavian CVC (p=0.2, RR= 1.35, 
95% CI 0.84-2.19). (Marik et al., 2012, 2482-2483) 
 
 
Evaluation of Evidence 
The literature reviewed does not provide clear clinical practice guidelines for best suited 
sterile dressing and anchoring methods for ECMO cannulas. However, knowledge and clinical 
practice guidelines aimed for central line dressings can be used to concoct a practical bundle 
approach for ECMO cannula insertion site care (ELSO Infections Disease Taskforce, 2019).   
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The literature reviewed suggests that there is a decrease in CLABSI rates when variables 
such as dressing change bundles, decreased frequency of dressing removal, use of CHG-
impregnated transparent dressings, or CHG-impregnated discs, and checklists are used for CVCs.  
At present, ELSO recommends the implementation of CLABSI bundles for bedside cannula care.  
Regarding CRIs, research defines a CRI as a positive blood culture during ECMO therapy; 
however, there is variability in the window of time around ECMO therapy in which a positive 
blood culture would be considered related to the ECMO cannulas. 
There are several gaps in the evidence discovered and, at this time, the articles reviewed 
exposed that there is not a clear consensus for monitoring CRI.  The CRI window has been 
identified as 24-48 hours post-initiation of ECMO to 24 hours to 30 days after decannulation.  
This variation in the defined time window is due to some studies identifying ECMO cannulas as 
a surgical site, and others as an invasive device (Allou et al., 2019; Aubron et al., 2013; Corley et 
al., 2019; Schmidt et al., 2012; Silvetti et al., 2019).  The ELSO Infectious Disease Task Force 
does not define CRI. 
It is suspected that due to the lack of clear CRI criteria, there are currently no studies that 
analyze the success of implementing a cannula care bundle to the ECMO population.  The 
project leaders are heavily relying upon successful CLABSI reduction methods to apply to the 
ECMO cannula and patient population.  Heterogeneity for a care bundle of a central line 
compared to an ECMO cannula cannot be guaranteed. However, it is the current 
recommendation from the ELSO Infectious Disease Task Force to utilize this approach (2019).   
 
Theoretical Basis 
Synergy Model for Patient Care 
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The Synergy Model for Patient Care is a middle-range theory that was developed by the 
board of nurses from the American Association of Critical-Care Nurses (AACN) in the mid-
1990s.  The purpose of the Synergy Model is to articulate nursing contributions, activities, and 
outcomes regarding care for critically ill patients.  The original concept was designed to create a 
comprehensive exam that not only focused on the skill required for critical care nursing but also 
focused on holistic care of the patient and analyzes critical thinking skills.  This exam is the 
Critical Care Registered Nurse (CCRN) exam (McEwen & Ellis, 2019).  The conceptual 
framework of this model enhances nursing practice. It works to improve patient outcomes to 
adapt to the needs of the complex patient by identifying patient and nursing-specific strengths 
and weaknesses (Hardin & Kaplow, 2017).    
            The Synergy Model combines outcomes derived by the patient, the nurse, and the 
healthcare system by producing a joint effect between eight key nursing competencies and eight 
identified patient characteristics.  The eight nurse competencies include the following:  clinical 
judgment, clinical inquiry, facilitation of learning, collaboration, systems thinking, advocacy and 
moral agency, caring practices, and response to diversity (McEwen & Wills, 2019).  These nurse 
competencies reflect an integration of knowledge, beliefs, skills, and attitude that are needed to 
optimize care for patients, improve patient outcomes, and reflect a level of skill that is required 
to care for critically ill patients (Hardin & Kaplow, 2017).  The eight patient characteristics 
described in the Synergy Model include the following:  resiliency, vulnerability, stability, 
complexity, resource availability, participation in care, participation in decision making, and 
predictability.  These patient characteristics consider the physical, social, psychological, and 
spiritual aspects of the patients shift the focus to holistic care and fosters a healing environment 
(Hardin & Kaplow, 2017).  
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The patient's needs to drive the nursing competencies that are needed for the care of the 
patient (Hardin & Kaplow, 2017).  In congruence with the cannula care bundle implementation, 
the patient’s complexity will require nursing clinical inquiry and systems thinking.  The 
physiological complexity of the ECMO patient requires diligent care from the bedside nurse and 
the ECMO nurse specialist.  Project leaders will depend on the clinical inquiry of the bedside 
providers to adjust dressing practices based on expert opinion as needed, as there are limited 
supplies available that are intended for cannula dressings.  Systems thinking refers to the “body 
of knowledge and tools that empower the nurse to manage environmental and system resources 
for the patient” (Hardin & Kaplow, p.105, 2017).  Project leaders will need the systems thinking 
of leadership in the cardiovascular ICU (CVICU) to obtain appropriate supplies and successfully 
implement the project.   
 
APPLICATION OF THE EVIDENCE 
 
Problem Identification.  
At a large medical institution in the Midwestern United States, the 32-bed CVICU cares 
for an average of 100 venovenous (VV) and venoarterial (VA) ECMO patients per year (Allina 
Health, 2019). Please refer to Figure 1 for a reference to the institution specific ECMO program 
growth.  The institution’s current policy for ECMO cannula site care and dressings is to utilize 
the current CLABSI bundle protocol for dressing the cannulas sterilely, as recommended by 
ELSO. However, often the size of the dressing, the chlorhexidine gluconate-impregnated 
antimicrobial disc, and other supplies are inadequate to dress the cannula appropriately.  Nurses 
are forced to implement inconsistent and individualized strategies to appropriately cover the 
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ECMO cannula insertion site and maintain sterility, resulting in a lack of continuity in practice 
and difficulty replicating effective strategies.   
All ECMO specialists and bedside nurses trained to care for ECMO patients were 
informally surveyed as part of the unit’s quality improvement practice initiative on current 
dressing practices for the ECMO cannula insertion site.  Of the responding nurses, 70% use their 
own combination of materials to sterilely provide site care for the insertion site, since there are 
no designated supplies or protocols specific to ECMO cannula site care.  The remaining 30% 
solely used a central line site care kit. The most common reasons for changing the cannula site 
dressing followed by the percent of responders selecting the rationale were the following: 
bloody/saturated dressings (97%), dressing no longer intact (89%), dressing was removed for a 
procedure (51%), or the dressing was due to be changed (51%). 
Of the respondents, only 32% of nurses believed that the central line dressing kit 
provided adequate supplies for ECMO cannula site dressing changes.  The remaining nurses 
stated that the central line dressing kits provided dressings and BioPatches that were too small, 
the site cleaning supplies were inadequate, and there was an insufficient amount of skin 
protectant provided (Cavilon barrier).  About 10 responders indicated in the free text or comment 
sections that the addition of a 10”x4” Tegaderm in commonly used when the central line 
Tegaderm is not adequate to provide occlusive coverage over the insertion site.   
Nearly 70% of the responding nurses indicated that they felt the current cannula anchor 
practices either were sometimes or never provided adequate prevention of movement and 
migration of the ECMO cannulas.  The methods for cannula securement indicated by the 
surveyed nurses included either a combination or singular use of the following methods: suturing 
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to the skin (88.9%) or a Stat-lok or Hollister tube attachment device seen in Figure 2 (86%), 
taping to the skin (15%).   
Based on nursing response, there is a need for generating a kit that is specific to the 
peripheral ECMO cannula site.  The nursing staff have expressed that there are multiple different 
methods for providing site care to an ECMO cannula site, resulting in a discontinuity in practice.  
Furthermore, the inadequate sizing of the products that are used results in nursing staff using 
additional resource to create an occlusive barrier around the insertion site.  Investigating better 
suited supplies for ECMO cannula sites will not only allow for a consistent care method, but 
eliminate the use of extra Tegaderms, chlorhexidine swabs, extra BioPatches, anchoring device, 
and barrier swabs that are used for these sites. A secondary outcome of the bundled approach to 
dressing the ECMO cannula insertion site is a simplified charging process in which all the 
materials used will be clustered in one charge as opposed to each materially individually. 
 
Figure 2. 
To the left is the Maquet StatLok tube securement.  To the right is the Hollister vertical tube 
securement.   
 
Utility and feasibility. 
The cannula site care bundle is a clinically feasible evidence-based intervention.  There 
are two major benefits of the Cannula Site Care Bundle which would include a unified approach 
to ECMO cannulation site care, and potentially a decreased risk for CRI.  By providing a unified 
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approach, this will allow for all nursing staff to follow a designated flow as to how the site care 
should be completed.  A potential risk of this project is that the CLABSI data investigated is not 
translatable to the ECMO cannula site and using a CLABSI approach and products that are not 
specifically designed for the ECMO cannula site could increase infection risk.  The risk to the 
patient is the same in the project implementation phase as it is with current ECMO cannula site 
care practices; therefore, this project would not impose an increased risk.   
The DNP students presented the proposed project to key stakeholders of the project.  The 
cannula site care bundle was approved by the ECMO nurse specialist group on October 14, 2020, 
and the Cardiovascular ICU Breakthrough committee (CV Breakthrough) on October 13, 2020.  
CV Breakthrough consists of representation from each of the following teams that primarily 
provide patient care on the unit: cardiology service, heart failure service, hospitalist service, 
intensivist service, cardiovascular surgery service, vascular surgery service, infectious disease 
service, CVICU nursing management, the CVICU clinical nurse specialist, the patient care 
director, respiratory therapy, pharmacy, infection prevention, and CVICU bedside nursing staff.   
 
Recommendations based on literature. 
The literature reviewed suggests that there is a decrease in CLABSI rates when variables 
such as dressing change bundles, decreased frequency of dressing removal, the use of 
chlorhexidine gluconate (CHG) impregnated transparent dressings or CHG-impregnated discs, 
and checklists are used for central venous catheters (CVCs).  ELSO recommends the 
implementation of CLABSI bundles for bedside cannula care.  The research defines a CRI as a 
positive blood culture during ECMO therapy, although there currently is not a process for 
monitoring or tracking CRI.  
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The proposed ECMO cannula site bundle kit will consist of the following items: 
• 1 – central line dressing kit, which includes: 
o Clean gloves 
o Sterile gloves 
o Hand sanitizer 
o Mask 
o 1 – cavilon barrier (medium) 
o 1 – Prevantics swabstick 
o 1 – sterile drape 
o 1 – 4” x 4” gauze 
• 1 - 4” x 6” chlorhexidine impregnated dressing 
• 1 – Cavilon barrier swab (small) 
• 1 – Bioderm anchor 
• 1 – additional Pevantics swabstick 
The ECMO Cannula Site Care Bundle consist of a kit including a central line dressing kit 
and the additional supplies.  The following supplies from the central line dressing kit will not be 
used and will be refunded to the patient’s individualized charges using the PAR system: 3 line 
caps, large Tegaderm, BioPatch.  Once the nurse has completed dressing the cannula insertion 
site, the unused supplies will be returned to the baggy with the completed checklist.  The DNP 
students will then go back to refund PAR charges for the unused and unopened supplies.  This 
method has been selected by the project leaders because the specific ECMO Cannula Site Care 
kits cannot be constructed in time for the implementation phase of this project.  The central line 
dressing kit consists of many of the supplies that are needed for project implementation, and 
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therefore was the best option to implement the project within the determined timeline.  Creating 
the ECMO cannula site care kit is essential as it encourages the nurse to follow the evidence-
based steps for cannula insertion site care and places the necessary materials in one spot to 
simplify the process for gathering supplies.   
There are two primary supplies that will be different from the central line kit for this 
project: The CHG impregnated dressing and the cannula anchor. The CHG-impregnated dressing 
is a more appropriate dressing for the ECMO cannula site because it is larger than the current 
central line dressing (4” x 6.125” compared to 4” x 4.75”). Furthermore, there is currently no 
CHG-impregnated disc that is large enough to make contact around the entire circumference of 
the cannula at the insertion site as recommended by manufacturers for infection prevention.  A 
CHG impregnated dressing will provide better contact to the insertion site than a CHG 
impregnated disk.   
Current anchoring practices include the Maquet StatLock and the Hollister verticle tube 
anchor (Figure 2). These stabilization devices prevent the cannula from lifting off the skin, but 
do not prevent migration in and out of the insertion site.  The only known study investigating 
best cannula anchoring methods was done by Bull et al (2019). The two best anchors determined 
in this study were the Grip-Lok and MultiFix adhesive anchors, as these two anchors required the 
highest amount of force to dislodge a cannula in non-human subjects.  Both dressing adhere to 
both the cannula and the patient’s skin. When discussed with the stakeholders at the institution, 
the adhesion to the cannula was deemed to be undesirable because it could delay emergency 
needs in the event that the cannula would need to be manipulated by a provider.  Furthermore, 
the adhesive could leave residue on the cannula causing concern of someone inadvertently using 
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adhesive removal directly on the cannula which could in turn cause breakdown due to active 
ingredients in adhesive removal.  
    After product research and approval of CV Breakthrough and the ECMO nurse 
specialist team, the Bioderm dual anchor was selected as a primary product for ECMO patients 
(Figure 3).  The benefit of this product is the adhesive is appropriate for patients with fragile 
skin.  Also, there are two non-adhesive anchoring points, the anchor accommodates items up to a 
47 French (15.667 mm) diameter without risk of applying additional pressure on the cannula. 
The ties are quick release to allow for prompt manipulation when necessary without risk of 
residue on the cannula.  The ties are also a rubbery substance that sticks to the cannula without 
adhesives, which will reduce the risk of migration in and out of the insertion site when used in 
conjunction with insertion site sutures. 
Dressing changes will occur on all peripherally inserted ECMO cannulas every seven 
days and as need when the dressing is soiled as recommended by current CLABSI guidelines.  If 
the site requires a hemostatic dressing, they will require changing within two days (CDC, 2017).  
This is the current policy for central line dressings at the institution.  A checklist has been created 
and can be viewed in Appendix J to guide the nurses in the dressing change practice. 
Figure 3. 
Bioderm cathgrip securement device 
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Plan for Implementation of EBP Change 
The implementation of this project is planned to take place once the project and 
Institutional Review Board approvals have been obtained.  The goal timeline for implementation 
would be by December 14, 2020.  In order to have as large of sample size as possible and 
complete the data analysis and dissertation of the DNP project by the end of May, the 
implementation period will take place over a three-week period ending January 4, 2021.   
Prior to the implementation phase, Institutional Review Board (IRB) approval will be 
obtained, and the project leaders will train all 16 ECMO nurse specialists in the procedures and 
documentation process related to the ECMO cannula site care kit.  During this three-week 
period, one of the project leaders will either be on site, or digitally available via Zoom during 
shift change times to discuss any questions with the assigned ECMO specialist for the shift.  
During these shift check ins, the project leaders will review any dressing changes that had 
occurred, discuss documentation, and assess the availability of pre-made site care kits for future 
dressing changes.  Weekly email updates will be sent to the staff in the ECMO unit as well as an 
initial email prior to the implementation phase. These emails will serve as reminders and updates 
of this practice change. 
 
Evidence-Based Practice Model 
The Johns Hopkins Nursing Evidence-Based Practice Model (JHNEBP) was selected as 
the evidence-based practice (EBP) model to best guide this project. The DNP students chose this 
EBP model because of its emphasis on using the best evidence available to solidify the 
foundations of nursing practice. This philosophy of practice is guided by translating research into 
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application and teaches valuable lessons in autonomy and leadership by engaging in research 
with interdisciplinary colleagues.  The JHNEBP model can be viewed in Figure 4.  
The JHNEBP process to develop nursing-led best practice implements a three-part 
process for gathering evidence and disseminating this evidence into practice and is designed to 
meet the needs of the practicing nurse researcher by offering a nursing-centered problem-solving 
approach to clinical decision making. This research process within the practice model is referred 
to as PET: Practice question, Evidence, and Translation and offers a cyclical approach to practice 
and learning from research after discoveries are made. 
The process begins with a general inquiry within nursing and transitions into the PET-
phase of the process, to which Appendix I offers greater detail regarding the PET-phase of the 
JHNEBP model. After the translation phase of this model the evidence goes into a period of 
appraisal where the evidence is scoured for quality, consistency, and applicability before any 
publication and dissemination are conducted.   
Figure 4 
Johns Hopkins Nursing Evidence-Based Practice Model  
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Participants and project setting.   
The project will be implemented in the CVICU at a Twin Cities level III trauma center 
and teaching hospital that offers peripherally cannulated VA and VV ECMO.  All centrally 
cannulated patients will be excluded from the project, as this population requires a unique 
ECMO cannula dressing that is to be changed by the cardiac surgical staff per the facility’s 
policy.  All ECMO patients at this institution are cared for in its 32-bed CVICU, therefore 
project implementation will occur on this unit.   
Applications for the Internal Review Board (IRB) at both Abbott Northwestern Hospital 
and Winona State University will be submitted with guidance from Sharon Wahl of Abbott 
Northwestern Hospital and Dr. Kimberly Langer of Winona State University. 
 
Readiness for change.   
Facilitators of this project will be the clinical nurse specialist (CNS) for the 
cardiovascular intensive care unit (CVICU) at the medical institution, Sharon Wahl, who is the 
DNP Project mentor.  Sharon will facilitate access to the institution’s ECMO data as well as 
assist in forming key relationships with stakeholders of the project.  The ECMO nurse specialists 
and the ECMO educator will also prove to be a vital component to the project, as successful 
implementation will depend on their participation in training to ensure adequate education on the 
new cannula site care methods.   
Barriers include a likely small sample size during the implementation phase due to the 
rare nature of ECMO cannulation and the relatively short implementation timeframe.  Despite 
the high probability of a small sample size, there is a clear need for evidence surrounding 
cannula site care; therefore, data will be analyzed regardless of the sample size obtained during 
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the implementation phase.  This potentiates the ability for future projects among other 
institutions to branch off from this original research and allow for an eventual multi-center 
implementation within the institution’s system.   
 
Process for meeting supply needs.  
The unit managers will assist the project leaders in special ordering the materials for the 
Cannula Site Care Bundle.  This budget has been approved by Mark Ebeling, the Cardiovascular 
Emergencies Director, and it will be charged to the ECMO cost center per the approval of the 
CVICU managers.   
 It is estimated that, for a 3-week implementation period, the project leaders will need to 
generate roughly 20 kits.  The project leaders have requested 50 CHG dressings and 30 Bioderm 
Cathgrip anchors to be special ordered. This estimate is based on the roughly 100 ECMO 
patients seen at this facility per year and guidelines for frequency of dressing changes.  The 
dressings will be changed once every seven days, and when visibly soiled to the point of a loss in 
dressing integrity.  The anchors will be less prone to soiling and will not require changing as 
frequently as the CHG dressing since they will be located on the opposite shoulder for IJ 
cannulation and outside the femoral cannula dressing for femoral cannulation.  The project 
leaders will monitor the stock of ECMO dressing kits every week and generate additional kits as 
needed.  One extra kit will be utilized for training purposes.   
 
Training methods.  
Eight of the 16 ECMO nurse specialists will be trained in the process for application of 
the Cannula Site Care Bundle in the ECMO nurse education days occurring on December 3rd 
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and 4th, 2020.  The remaining eight ECMO nurse specialists will be trained at the monthly 
ECMO specialist meeting that occurs on December 9th, 2020.  Any nurses that are unable to 
attend this meeting date, that still require training will be approached individually for training by 
the DNP students.  Training days have been approved by the unit’s nursing management, as well 
as the ECMO nurse educator.  This training will involve no additional hours beyond the nurse’s 
individual work agreement, as training time will be incorporated in meetings that are already 
planned.  Training is estimated to take 30 minutes in a group setting, and 15 minutes 
individually.  The project leaders will be the sole educators providing the education for the site 
care process to guarantee consistency in educational delivery with teach back to assess for an 
appropriate level of understanding by the ECMO nurses and specialists.   
The group of 16 ECMO nurse specialists will be responsible for all dressing changes on 
the ECMO cannula site for patients in the CVICU for the duration of this project.  This will be 
most efficient to train this small specialized group during the pre-scheduled education days as 
opposed to training all 72 bedside nurses that care for ECMO patient who does not have frequent 
access to the simulation lab.  The operating room technicians and the cardiac catheterization lab 
technicians who place the initial dressing immediately after cannulation will also be excluded 
from the cannula care bundle training.  Cannulas frequently bleed for up to two hours post-
cannulation, requiring a dressing change once the patient arrives in the CVICU.  For this reason, 
the cardiac catheterization lab technicians will not require training at this time.  A brief 
presentation will be offered to the cardiac catheterization lab technicians and the operating room 
technicians to provide education about the project with the understanding that the project may 
eventually be implemented on these departments pending the outcomes of the project.  
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Measurement methods.  
Primary outcomes. 
Data will be collected in the pre and post intervention cohort comparing the frequency of 
required dressing changes and the rationale for changing the dressing.  The DNP students expect 
that by creating methodological approach specifically designed for ECMO cannula insertion site 
care will yield less frequent dressing changes and lower incidence of saturated and/or no longer 
intact cannula dressings.  After the implementation period has has completed, the DNP students 
will look at the number of dressing changes as well as rationale for changing the dressing in the 
Cannula Site Care Bundle cohort will be collected and the data compared to pre implementation 
data.  Successful implementation would be indicated by a statistically significant decrease in the 
number of dressing changes and/or the number of blood dressings in the “cannula site care 
bundle” cohort.   
The success of this project will also be determined by valued input from the 16 nursing 
ECMO specialists.  After the implementation phase is complete, all 16 ECMO nurse specialists 
will be surveyed on their satisfaction with the new ECMO Cannula Site Care bundle and provide 
context for feedback.  The goal of this project is to provide the nursing staff with evidence-based 
guidance to create a unified approach to caring for the ECMO cannula insertion site and improve 
the workflow for the nursing staff by providing the bundled kit and to allow for streamlined 
process of ECMO Cannula site care.  This survey can be viewed in Appendix K. 
 
Secondary outcomes. 
The DNP students expect that by applying similar practices used in CLABSI bundles, 
that incidences of cannula dislodgement and CRIs will be decreased in the post intervention 
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cohort. These secondary outcomes will be challenging to measure in the expected small sample 
population during the implementation phase of the project.  For the purpose of this project, a 
positive CRI will be defined as a positive blood culture that occurs in an ECMO patient 24 hours 
after cannulation to 48 hours after decannulation.  This timeframe has been agreed upon by 
Sharon Wahl, CNS, and is the current timeframe for defining a CLABSI according to the CDC 
(2017) and the institution’s policy.  The insulting organism will also be recorded. 
 
Project parameter definitions. 
For further clarification, below are parameter definitions: 
• Pre-intervention cohort: All ECMO patients with peripherally inserted ECMO cannulas 
from December 14, 2019 to January 4, 2020. 
• ECMO Cannula Site Care Bundle cohort or post intervention cohort:  All ECMO patients 
with peripherally inserted ECMO cannulas that underwent the Cannula Site Care Bundle 
for dressing changes from December 14, 2020 to January 4, 2021. 
• CRI: A positive blood culture resulted on an ECMO patient 24 hours after cannulation to 
48 hours after decannulation. 
A list of confounding factors for comparison of the pre and post intervention cohorts was 
generated by the project leaders and can be seen in Appendix L.  The data will be appropriately 
adjusted for age, race, admitting diagnosis, environment the cannulation occurred, and other 
factors of interest.  Once the baseline data is collected, a benchmark for the number of dressing 
changes required and rank of most common reasons for dressing changes will provide a 
benchmark for the intervention cohort.  The pre-intervention cohort will consist of all 
peripherally cannulated ECMO patient from December 14, 2019 to January 4, 2020. 
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Data collection process.  
The DNP students will conduct the pre-intervention and post-intervention data analysis 
with the assistance of Sharon Wahl, CNS and the data analysts employed by the institution.  A 
statistician is available at the institution and will be contacted prior to beginning the data analysis 
for consultation.  Once the DNP students can meet with these key persons, and data collection 
plan will be finalized.   
 
Plan for data analysis. 
Data analysis will be conducted by the DNP students using JMP Statistical Analysis 
Software with consultation from the Statistical Department at Winona State University. 
 
Resources, proposed budget, and timeline.   
There will be no need for increased work hours for the staff implementing the project, as 
training will take place during the quarterly ECMO nurse specialist education days and meeting 
days.  A cost analysis the ECMO cannula care bundle is available in Appendix H.  Appendix H 
offers a cost breakdown comparing current ECMO cannula dressing methods to the proposed 
ECMO Cannula Site Care Bundle.  The total cost for the supplies requested for the 
implementation phase of this project is $596.79.  This includes 50 CHG impregnated dressings 
and 30 Bioderm Cathgrip anchors.  No additional cost will be accrued with training the ECMO 
nurse specialists as all training will occur within the nurses’ current work agreement. 
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The budget for this project has been marked to be included in hospital site’s ECMO 
program costs and included as part of the hospital’s ECMO budget.  This budget has been 
approved by Mark Ebeling, the Director of Cardiovascular Emergencies. 
 
Summary plan for implementation. 
In summary, the 16 ECMO nurse specialists will begin training during the ECMO nurse 
education days in December.  Any nurses that are not trained during that time will either be 
approached individually or received training during the ECMO specialist meeting on December 
9th.  The implementation period is planned for December 14th 2020 to January 4th 2021.  The 
CHG impregnated dressing and the Bioderm Cathgrip anchor will be special ordered by the 
CVICU nurse management near the end of October.  All budgeting has been approved by the 
Director of Cardiovascular Emergencies. 
Conclusion 
In conclusion, based on the lack of data and efficacy of ECMO cannula dressing bundles 
the project coordinators make the argument that this project is both necessary as a means for 
increasing cannula site stability, while also decreasing CRIs. By implementing and creating 
research that works at creating a best practice model for increased ECMO cannula site stability, 
the DNP students will attempt to fill this gap in knowledge that benefits many ECMO patients in 
years to come. By embarking on this research, both Winona State University and the medical 
institution have the opportunity at sharing credit in any new discoveries and achievements that 
are made with the implementation of this project, while also continuing a relationship that strives 
for the best outcomes in patient safety, research, and education. As students working within both 
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organizations, we take pride in fostering these relationships and creating research that will be a 
positive reflection of both institutions with the dissemination of this research. 
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Allou et al., 
2019 
Cannula-related infection in patient supported by 
peripheral ECMO: clinical and microbial 
characteristics 




Infections acquired by adults who receive 
extracorporeal membrane oxygenation: risk factors 
and outcomes 
Included – identifies risk factors for patients that have nosocomial 
infections during ECMO therapy  
Biffi et al., 
2017 
Infections during extracorporeal membrane 
oxygenation: epidemiology, risk factors, 
pathogenesis and prevention 
Included – a thorough literature review of available data on 
nosocomial infections during ECMO therapy 
Bull et al., 
2018  
Extracorporeal membrane oxygenation line-
associated complications: in vitro testing of 
cyanoacrylate tissue adhesive and securement 
devices to prevent infection and dislodgment 
Included – analyzes different dressing/securement methods and 
measures the force required to dislodge a cannula.   
Bull et al., 
2019 
Cannula and circuit management in peripheral 
extracorporeal membrane oxygenation: an 
international survey of 45 countries. 
Included – compares different methods for cannula care amongst 
ELSO registered facilities. 
Corley et 
al., 2019 
Nosocomial infection prevalence in patient 
undergoing extracorporeal membrane oxygenation: 
protocol for point of prevalence study across 
Australia and New Zealand 
Included – this study is not yet complete but has excellent 
information for possible outcome measurement strategies related 
to the project. 
Grigonis et 
al., 2016 
Use of a central catheter maintenance bundle in 
long-term acute care hospitals. 
Included – Assesses pre-implementation to post-implementation 
CLABSIs rates in a single-center acute care hospital. 
Hahne et al., 
2015 
Cannula-related infection in adult medical 
intensive care unit patients undergoing 
extracorporeal life support and extracorporeal 
membrane oxygenation 
Included – investigates possible risk factors associate with 
cannula related infections.   
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The risk of catheter-related bloodstream infection 
with femoral venous catheter as compared to 
subclavian and internal jugular venous catheters: A 
systematic review of the literature and meta-
analysis. 
Included – Reviews the literature to determine the risk of 
catheter0related bloodstream infections related to non-tunneled 
CVCs inserted at the femoral site as compared to subclavian and 
internal jugular venous placement. 
Mitchell et 
al., 2019 
Central venous access device securement and 
dressing effectiveness: The CASCADE pilot 
randomized controlled trial in the adult intensive 
care. 
Included – Tests the feasibility of an RCT comparing “standard” 
care with three dressing and securement products to prevent 
central venous access device failure and compares dressing and 
securement products on failure rates, microbial colonization, and 
intervention costs. 
Silvetti et 
al., 2019  
Bloodstream infections during post-cardiotomy 
extracorporeal membrane oxygenation: incidence, 
risk factors, and outcomes 
Included – Identifies risk factors for BSI in the ECMO 
population, particularly post-cardiotomy patients who are usually 
placed on prophylactic antibiotics 
Spencer, 
2018 
Securing vascular access devices: Using the right 
securement method can improve outcomes and 
decrease cost.   
Included – thoughtful discussion of different available products 
for CVC securement, may apply to cannulas 
Tignanelli et 
al., 2019  
Optimal methods to secure extracorporeal 
membrane oxygenation  
Included – an expert opinion on securement methods for RIJ 
cannulas, no other data available.  
Timsit et al., 
2012 
Dressing disruption is a significant risk factor for 
catheter-related infections. 
Included – the article is a secondary analysis of dressing study 
performed in ICUs across multiple sites. 
Ullman et 
al., 2015 
Dressings and securement devices for central 
venous catheters (CVC). 
Included - Compares the available dressing and securement 
devices for CVCs in terms of BSIs, catheter colonization entry, 
and exit-site infection, skin colonization, skin irritation, failed 
catheter securement, dressing condition, and mortality. 
Vogel et al., 
2011 
Defining risk for infectious complications on 
extracorporeal life support 
Included – research for identified risk factors associated with CRI 
Webster et 
al., 2017 
Chlorhexidine gluconate or polyhexamethylene 
biguanide disc dressing to reduce the incidence of 
central-line-associated bloodstream infection: a 
feasibility randomized controlled trial (the 
CLABSI trial). 
Included – Investigates the feasibility and safety of comparing 
two antimicrobial-impregnated discs to prevent CLABSI. 
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Wichmann 
et al., 2018 
Efficacy of introducing a checklist to reduce 
central venous line-associated bloodstream 
infections in the ICU caring for adult patients. 
Included – Tests the inclusion of a procedural checklist to a 
CLABSI bundle to enforce its efficacy and reduction of infection 
rates. 
Yu et al., 
2019 
Chlorhexidine gluconate transparent dressing does 
not decrease central line-associated bloodstream 
infection in critically ill patients: A randomized 
controlled trial. 






The use of polyurethane transparent film in 
indwelling central venous catheter. 
Excluded – Small sample population and lack of supporting 
statistical analyses. 
Glater et al., 
2016 
Nosocomial bloodstream infection in patients 
receiving extracorporeal life support: variability in 
prevention practices: a survey of the ELSO 
members 




Medical adhesive-related skin injuries associated 
with vascular access 
Excluded – discussed possible adhesive-related skin injury, but 
did not provide any data or product associations with different 
types of dressings 
Kao et al., 
2011 
Antimicrobial prophylaxis and infection 
surveillance in extracorporeal membrane 
oxygenation patients: a multi-institutional survey 
of practice patterns 
Excluded – the article is focused on microbial analysis and 




Effects of prone positioning on cannula function 
and impair oxygenation during extracorporeal 
circulation 
Excluded – did not discuss methods for securing cannulas or 
dressing cannulas before proning patient 
Scheithauer 
et al., 2013 
Reduction of central venous line-associated 
bloodstream infection rates by using a 
chlorhexidine-containing dressing. 
Excluded – Study was funded by 3M and had several limitations 
in the study, namely limited to a single-center. 
Wells et al., 
2018 
Safety and feasibility of early physical therapy for 
patients on extracorporeal membrane oxygenator 
Excluded – did not discuss cannula securement needs with 
increased patient mobility 
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Appendix B 
Search Parameters for Data Collection 
 











1/25/20  “ECMO” and “Dislodgement”  Pubmed  10  4  2  
  
1/25/20  “Extracorporeal membrane oxygenation” and 
“cannula” and “management”  
Pubmed  101  8  1  
1/29/20  “central venous catheters” and “securement” or 
“anchor”  
CINAHL  106  9  1  
1/29/20  
 
“central venous catheters” and “securement”  Cochrane Library  7  1  1  
2/1/20  “cannula-related” and “infection” and 
“extracorporeal”  
Pubmed  7  3  2  
2/1/20  “extracorporeal” and “acquire infection” and 
“risk factors  
Pubmed  39  4  2  
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2/1/20 "Catheter-related bloodstream infection" Cochrane Library 18 2 1 
2/1/20 "Catheter-related bloodstream infection" and 
"chlorhexidine gluconate: 
CINAHL 51 13 4 
2/1/20 "central line-associated bloodstream infections" 
or “clabsi” and “ICU" 
CINAHL 23 2 1 
2/1/20 “clabsi bundle” and “ICU" ProQuest 22 2 1 
2/1/20 “clabsi” and “femoral vein” ProQuest 105 18 3 
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Literature Review Table 




Variables, methods for 
measurement 
Findings Implications Level of 
Evidence 
Allou, N., Pinto, 







Dangers, L., & 
Allyn, J. (2019). 
Cannula-related 














Provide data to 

































ECMO or had 
peripheral 
ECMO for 















sterilely removed at 
the end of ECMO 
therapy.  When a CRI 
was suspected, the 
tips were sterilely cut 
and send for 
microbial analysis 
 





every 2 days.   
 
Prophylactic 




surgery.  antibiotics 
were initiated once 
CRI was suspected. 
Variables associated with 
CRI were assessed by 
comparing CRI patients to 
those without CRI that 
underwent ECMO therapy. 
 
Suspected CRI was defined 
at the facility in this study 
as having one or all of the 
following signs: local signs 
of infection at insertion site, 
positive culture from either 
the site of infection via 
needle aspiration or surgical 
exploration or infection 
occurring within 30 days 
after ECMO insertion 
(defined by CDC as a 
surgical site infection)   
Blood cultures were only 
performed when an 
infection was suspected. 
 
ICU length of stay, hospital 
length of stay, and in 
hospital mortality was also 
analyze when comparing 
CRI to non-CRI ECMO 
patients 
   
39 cases of CRI were 
diagnosed 9 days after 
cannulation (17.7%) 
 
Incidence of CRI was 
17.2/ 1,000 ECMO days 
9.2/1,000 VV ECMO days 
23.6/1,000 VA ECMO 
days.   
 
significant variables for 
CRI risk were: renal 
replacement therapy 
(p=0.022),  
# of blood transfusions 
during ECMO support 
(p=0.02) 
ECMO median days 
(p=0.015). 
 
Antibiotic therapy at time 
of ECMO cannulation was 
not associated with 
reduced CRI (p=0.57) 
 
Median LOS in ICU was 
23 days in CRI group vs. 
15 in non-CRI group (p < 
0.001) 
Median hospital LOS was 
40 days in CRI and 24 in 
non-CRI (p = 0.002) 
Although did discuss 
standardized suturing 
technique used at 
facility, did not 
discuss standardized 
beside dressing and 
anchoring practices. 
 
Researchers in this 
article state that it is 
difficult to apply 
CLABSI bundles to 
ECMO dressing, but 
methods such as 
CHG bathing, 
antimicrobial 
dressings and other 
methods to prevent 
CLABSI need to be 
investigated in 




guidelines for CRI 
monitoring, these 
guidelines were 
decided by expert 
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Reference Purpose Sample, 
Setting 
Design, Framework Variables, methods for 
measurement 
Findings Implications Level of 
Evidence 
Aubron, C., 
Cheng, A. C., 
Pilcher, D., Leong, 
T., Magrin, G., 
Cooper, D. J., 
Scheinkestle, C., & 
Pellegrino, V. 
(2013). Infections 





















factors and the 
consequences 
on patient 















ECMO for > 
48 hours over 
the age of 16 
between Jan. 
2005 and 










patients.   
Retrospective 










considered if they 
occur within 72 hours 
after ECMO 
cessation or 48 hours 
after ECMO 
initiation.  All blood 
cultures were 
preferred to be done 
peripherally x2 or 
from central line if 
access was difficult 
based on CDC 
Guidelines.   
Patients did not routinely 
receive prophylactic 
antibiotics.   
 
Most common cannulation 
sites were bi-femoral with 
8fr distal perfusion catheter 
used for arterial cannula 
sites. 
 
Researchers also analyzed 
the following factors: 
APACHE II, SOFA score, 
Pao2:FiO2 ratio, 
hematological malignancy, 
occurrence of cardiac arrest, 
lactate on initiation of 
ECMO.  ICU days and 
duration of mechanical 
ventilation before ECMO, 
indication for renal 
replacement therapy while 
on ECMO. 
 
24 patients experienced a 
blood stream infection.  
Rate of bloodstream 
infection (BSI) was 15.7 
cases per 1,000 ECMO 
days.   
 
Statistically significant risk 
factors for blood stream 
infections on ECMO were 
the following:  Duration of 
ECMO days (p=0.0004), 
total units of RBC 
transfused (p=0.0092). 
 
Hospital LOS after ECMO 
weaning was longer in the 
infected cohort compared 
to the non-infected, but not 
significant (p=0.0845).  In-
hospital mortality was not 
statistically significant 
(p=0.457)   
 
Nearly 25% of ECMO 
patients in this study 










Researchers did not 
state what the 
infection prevention 
practices were for the 




bundles or CAUTI 
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Reference Purpose Sample, 
Setting 
Design, Framework Variables, methods for 
measurement 
Findings Implications Level of 
Evidence 
Biffi, S., Di Bella, 
S., Scaravilli, V., 
Peri, A. M., 
Grasselli, G., 
Alagna, L., 
Pesenti, A., & 



























l overview and 
identify 
underlying risk 











ecmo OR ecls 












All articles that 
discussed 
epidemiology, 
etiology, risk factors 
and/or pathogenesis 
of infectious disease 
in the abstract were 






of the ELSO 
infectious disease 




literature review was 
updated last on 
August 2, 2016.   
 
The following themes were 
discovered in the literature 
review:  incidence and 
prevalence, impact of 
infections on mortality rate 







duration of ECMO, etiology 
of infection, preventative 
practices and, antibiotic 
usage on ECMO  
Prevalence of hospital 
acquired infections during 
ECMO 10-12%., up to 
20% in adult subgroup.   
 
Prevalence and incidence 
of infectious episodes 
among adults range from 
9-65% and 12-75 cases per 
1,000 ECMO days 
 
Prevelance of blood stream 
infections range from 3-
18% and incidence ranges 
from 2.98 to 20.55 per 
1000 ECMO days 
 
Study by Steiner, et al. 
Observed a three-fold risk 
of death in patients 
experiencing blood stream 
infection during ECMO 
treatment.   
 
No studies were found that 
analyzed implementation 
of a dressing protocol or 









Highlighted need for 
a more standardized 
approach to cannula 
care for infection 
prevention 
 
Limitation is the age 
of the research that 
was reviewed.  Last 
literature search was 
August 2016, but no 
limitation set on 
earliest year for 
studies included.  
Some research 
reviewed is from 
1996. 
V 
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Reference Purpose Sample, 
Setting 
Design, Framework Variables, methods for 
measurement 
Findings Implications Level of 
Evidence 
Bull, T., Corley, 
A., Smyth, D. J., 
McMillan, D. 
J., Dunster, K. R., 






ations: in vitro 
testing of 
cyanoacrylate 



































In vitro (test 
tube) in a lab 
setting using 
adult pig 
skins.   
 
Location of 
this study was 




Sample size of 18 
cannulated pig skins 
were grouped in the 
following tubing 
securement cohorts: 
1) Grip-lok Universal 
securement device 2) 
MultiFix Unifix 
Universal Tube and 
Catheter Securement 
and 3) Tensoplast 
elastic adhesive 
bandage   
 
Second analysis was 
done to compare 
Dermabond to 
adhesive dressings 
for insertion site 
securement.  Each 
cohort had 6 pig skin 
samples. 
 
The force required to 
pull the cannula from 






13cm x 20cm pig skin 
sample obtained 
immediately after animal 
was euthanized.  The 
samples were taken from a 
standard area of each pig.  
Sample encased in a metal 
frame had a simulated 
ECMO site using 21F 
venous canula. Standard 
cannulation methods were 
practiced when placing 
cannula (use of dilators). 
 
The tubing cohorts had 
securement devices placed 
20cm away from the 
insertion site. 
 
The Dermabond cohort for 
the insertion site segment 
had 0.5mL of Dermabond 
placed at the insertion site 
and under the cannula 
extending ~7cm 
 
The adhesive only cohort 
for the insertion site 
segment had since layer of 
Opsite 10cm x 17cm 
covering cannula and left 
untouched for 5 min.   
 
Each skin was mounted 
onto tensile testing machine 
and pull-out force was 
measured. 
Dermabond significantly 
increased pull-out force 
required to remove 
cannula from skin 
compared to transparent 
dressing (p<0.0001) 
 
Grip-lok (92.0 N) device 
and Multifix (94.8 N) 
device required very 
similar forces to remove 
cannula securement 
device, but were both 
significantly higher 
(p<0.01) forces than the 
Tensoplast (56.2 N) 
 
Dermabond removal agent 
significantly weakens the 
cannula 1 h after exposure 
(p < 0.01) 
Grip-lok and Multifix 
may be feasible 
securement for 
tubing.   
 
Dermabond is an 
interesting approach, 
concern that once 
placed on insertion 
site may cause 
problems for skin.  
Also, unable to 
manipulate cannula 
after it is placed on 




Need to note that this 
is not a human trial, 
and sample sizes are 
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survey of 45 
countries. Pubic 




































from U.S., 32 



















and line securement, 
circuit access, 
guideline for ECMO 
line management 
practices 
The following questions 
related to literature review 
were asked for each theme: 
 
Cannula dressing and 
securement: frequency of 




technique used for dressing 
changes (sterile versus non-
sterile technique), 
procedures for accessing 
circuit, hand hygiene, 
preferred antiseptics 
 
Surveyors also asked if the 
facility had guidelines for 
cannula management and/or 




75% of facilities used 
transparent, semi-
permeable dressings, of 
this sample 21% used 
CHG dressing and 15% 
used CHG impregnated 
disc. No centers left 
dressings for > 7 days 
 
Securement: suturing to 
skin most common (45%), 
securing to bed/fixed 
object (19%), sutureless 
securement device (16%), 
adhesive fabric tape 
(10%). 
 
34% of facilities reported 
the occurrence of cannula 
line/dislodgement or 
accidental decannulation at 
their center in the last 5 
years.  61 centers reported 
that leading cause of 
malposition, dislodgement 
or decann was from 
inadequate securement 
 
78% of respondents 
reported having a written 
policy or guideline for 
ECMO line management 
 
CHG dressing products 
(dressings and disks) used 
at more than 50% of 
responding facilities 
Lack of standardized 





fixation to at least 2 
sites 
 





to use alternative 
securement devices. 
 
Limitations – not 
ALL practices are 
represented, mostly 
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for a point 
prevalence study 
across Australia 











































size for this 






at each facility 
screened ECMO 
patients for eligibility 
every week and 
completed a study-
specific care report 
on each eligible 
patient.   
 
The following data 













treatment within last 
48 hours, patients 
decannulated from 
ECMO >48 hours, 
patients with 
extracorporeal 
support without an 
oxygenator 
Blood stream infection 
define as at least one 
positive blood culture OR 
fever/chills and hypotension 
with at least 2 positive 
blood cultures (from 
separate samples) with a 
common skin contaminant 
within 48h of symptoms 
 
Surgical site infection 
(cannulation considered 
surgical site) includes 
infection within 30 days 
after insertion and 
discontinuation of cannula 
and one of the following: 
purulent drainage from 
incision, organism isolation 
from insertion site, 
pain/tenderness, swelling, 
redness at site, diagnosis by 
surgeon or intensivist 
 
Secondary outcomes that 
will be measured: insertion 
site dressing, length of time 
dressing was left on, tubing 
securement methods and 
number of tubing fixation 
points. 
 
Data analysis for this study 
began March 2019.  Data 
has not yet been published 
Study could have a 
huge impact on DNP 
project.  Particularly 
the information 
regarding types of 
dressing and methods 
for securement and 
anchoring 
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infection rates.   
Survey went 


























16-question survey to 
investigate practices 
for ECMO and 
infection prevention 
at institutions in the 
United States.   
 
Survey used an email 
format utilizing a 
web-based 
questionnaire. 
16-question survey asking 
the following themes: type 
of program (pediatric vs. 
adult), number of cases per 
year, infection prevention 
bundle implementation, 
practices for accessing 
circuit, dressings over 
insertion site and policy, 
antibiotic prophylaxis, BSI 
rate for ECMO patients (% 
per year = # culture proven 
infection / # of cases per 
year) 
 
27% of institutions used an 
infection prevention 
bundle at time of 
cannulation (i.e. antibiotic 
program). 
 
82.9% of facilities reported 
a “standard approach to 
cannula dressings was 
used”. 
 
57.3% of institutions used 
semi-permeable dressings 
 
60.49% of institutions 
reported changing cannula 
dressings only when 
soiled, 3.7% of facilities 
did not use a dressing.   
 
As the size of the program 
increased (# of cases), 
bloodstream infections 
increased (r = 0.52973, p < 
0.01).   
 
No correlation between 
BSI and infection 
prevention bundle 









bundle is not well 
defined in this study, 
but did not seem to 
have a significant 
impact on BSI  
 
Researchers highlight 
a large variability in 
prevention practices 
 
Researchers state that 
the efficacy of a 
standardized 
“bundle” approach to 





use of routine 
prophylactic 
antibiotics (excluding 
open chest) and 
surveillance cultures. 
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term acute care 
hospitals. America







To determine if 
a CLABSI 
bundle 
designed for an 
acute-care 
hospital will 
have the same 
reduction in 
CLABSI rates 
























30 LTACHs were 
selected out of 110 
initially surveyed. 
Data was collected 
retrospectively to 
establish a baseline 
analysis of CLABSI 
rates. Researchers 
collected data for 6 
months. 
Retrospective data 
was collected for 14 
months prior to the 
implementation and 
LTACH CLABSI 
rates were monitored 


















CLABSI bundle consisted 
of a bundled protocol, 
mandatory use of alcohol-
based CVC caps, CHG-
dressings, and the formation 
of a team of nurses that 
oversee the CVC 
maintenance within the 
LTACHs.  
Researchers tested for staff 
compliance by monitoring 
items like CVC dressing 
intactness and fully 
occlusive, date present on 
dressing, dressing initialed 
by staff, dressing changed in 
less than 7 days, daily 
assessments of dressing 




Infection Ratio (SIR) prior 
to bundle implementation 
was calculated at 1.28 
(95% CI 1.11-1.46) and 
post-implementation 
equaled 0.96. (p= 0.01, 
95% CI 0.82-1.12). 
Researchers proved 
that CLABSI bundles 
are just as effective 
in reducing the rate 
of CLABSIs outside 
of a standard hospital 
setting. 
Ancillary findings of 




dressings and the, 
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Fischer D, Köck R, 
Peters G, & 
Lebiedz P. 
Cannula-related 
infection in adult 
medical intensive 































analysis of the 
cannulas at the 





colinization.   
Medical ICU 








2013 to April 
















discontinued, and the 
tips of each cannula 
were sent for 
microbial analysis 
If a cannula related infection 
was suspected at the time of 
decannulation, one the 
central venous lines was 
also discontinued and 
cultured at the end of 
ECMO treatment 
 
Cannula related infection 
was assumed if microbial 
agent was found on both 
cannulas, one cannula plus a 
central line, or on a cannula 
plus a blood culture. 
 
The following potential risk 
factors were analyzed: age, 
gender, pre-existing 
infection, type of 
cannulation (emergent vs. 
urgent), positive blood 
culture, max SAPS II Score, 
infection other than blood 
stream infection during or 





15 patients were 
considered positive results 
for cannula related 
infection.  (15.9%) 
 
The statistically significant 
risk factors identified are 
pre-existing infection (p = 
0.099, OR 0.389), and 
positive blood culture (p = 
0.010, OR 4.762) 
 
Patients with an infection 
other than a bloodstream 
infection had higher odds 
of cannula related 
infection (OR 2.0), but this 
was not statistically 
significant (p = 0.292).  
Normal signs of 
bloodstream infection 





blood cultures are 
recommended by 
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Marik, P. E., 
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Harrison, W. 













































Systematic review of 
randomized 
controlled trials and 
cohort studies. 
Trials selected included 
relevant clinical trials that 
compared the risk of 
catheter-related blood 
stream infections for CVCs 
in the femoral vein, 
compared to the IJ vein.  
Data collected was for the 
adult population and all 
pediatric populations were 
excluded. 
Two statistical outliers 
were removed from 
analysis of the relative risk 
between femoral and IJ 
catheter-related 
bloodstream infections 
proved to have no 
statistical difference (RR= 
1.35, CI: 0.84-2.19 p=0.2). 
Meta regression analysis 
showed increased risk for 
infection in earlier studies, 
but not recent studies. This 
implies that there is no 
statistically significant 
difference between 
femoral CVC’s and those 
placed in the subclavian 























cannulae placed in 
the IJ and femoral 
regions of the body. 
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G., Powell, M., … 








controlled trial in 



















compared to a 
control group.  
Randomized 
controlled 







between four groups 











plus CHG dressing, 
and sutures, CHG 
disk plus integrated 
securement dressing.  
Study looked at skin 
impairment comparing the 
different adhesive 
dressings. Microbiological 
samples also showed an 
increased number of 
colonization despite CHG 





RCT showed that highest 
incidence rates (IR) of 
line failure was in the 
suture-less securement 
device (IR= 27.3, CI= 
11.4-65.6), then the 
control group (IR= 22.3, 
CI= 8.38-59.5), tissue 
adhesive group (IR= 20.6, 
CI= 6.66-64.0), and 
finally the group using the 
integrated securement 
device (IR= 8.8, CI= 
2.19-35.0). 
 
CVC failure, in this 
study, is defined as 
“any reason to 
discontinue the 




Rate of colonization 
shows increased risk 
for microbial 
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Trouillet, J., Pavie, 




































patients.   
 
Study took 








2003 and Dec 




BSI defined as 
infections occurring 
>24 hours after 
ECMO initiation and 
within 48 hours of 
discontinuation.  
Requires 2 or more 
positive blood 
cultures.   
 
Diagnoses of cannula 
infection required 
local signs of 
infection at access 
site with positive 
subcutaneous needle 




ECMO site dressings were 
changed every 2 days with 
transparent dressing and 
cleansed with chlorhexidine 
solution.   
 
When cannula related 
infections were suspected, 
needle aspirate was taking 
at insertion site. 
 
Blood cultures were taken 
for suspected BSI and 
venous catheter was 
removed and cultured. 
 
The following data was 
analyzed as potential risk 
factor for BSI: patient 
demographics, 
comorbidities, SOFA score, 
SAPS score II (both at 
admission), 
immunocompromised 
status, reason for ECMO, 
ICU days before ECMO, 
location of cannulation, site 







16 episodes of BSI per 
1,000 ECMO days 
 
Statistically significant risk 
factors for nosocomial 
infections are the 
following:  
immunocompromised 
patients (p = 0.02), acute 
myocardial infarction (p = 
0.04), heart transplant (p = 
0.007), patient cannulation 
in the ICU (p = 0.006), 
patient cannulation in the 
cardiac catheterization lab 
(p = 0.04).   
 
64% of ECMO patients 
developed a nosocomial 
infection during ECMO 




analyzing the risk 
factors, therefore it is 
unknow if the same 
risk factors are 




ECMO CANNULA CARE BUNDLE  66 
 
   
 
Reference Purpose Sample, 
Setting 
Design, Framework Variables, methods for 
measurement 




Pistuddi, V., Isgrò, 
G., Ballotta, A., 
Ferraris, L., & 


































































study.   
 
Patient factors that 
were analyzed:  adult 




time from surgery to 
ECMO implantation, 
ECMO under eCPR, 
serum creatinine and 








were used in this 
population. 
 
ECMO related BSI defined 
as a new positive blood 
culture occurring from 48h 
after ECMO initiation or 
48h after discontinuation. 
14 patients (15.2%) 
developed a BSI during 
defined ECMO-related 
criteria – 24.7 BSI per 
1,000 ECMO days.   
 
Mortality in BSI patients 
was 50% and 23.1% in 
those without BSI 
(p=0.05) 
 
No statistically significant 
difference in BSI in 
peripheral vs. Central 
cannulation (p=0.811) nor 
in the number of blood 
transfusions (p=0.960).   
 
Serum bilirubin 
significantly higher in 
patients that suffered BSI 
on ECMO (p=0.010) 
Adult patients are 
more susceptible to 
BSI than pediatric 
patients in this study. 
 
Highest recorded 
CRI infection rate 
found in literature 




antibiotics.   
IV 
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and reduce costs. 
American Nurse 
Today, 13(9), 29–
























Expert opinion The article discussed four 
different methods for 
securement of central lines: 
Suture, adhesive dressings, 
subcutaneous anchors and 
cyanacrylate.  Further 
discussion under “findings” 
 
Sutures: placed near 
insertions site.  Causes 
barrier for adequately 
cleaning beneath the 
catheter 
 
Adhesives: quick, simple 
application.  Strong 
adhesives cause skin 
damage over time 
 
Subcutaneous: Anchor 
placed to subcutaneous 
tissue.  Within 72 hours, 
anchor heals into place.  





method, little evidence 
although preliminary 
studies are showing glue 
may help inhibit gram + 
organisms from entering 
the blood stream.  




made in this article as 
to how time-
consuming 
application was for 
central line anchors.  
The writer believes 
the rationale for 
sutures and adhesives 
as primary means for 
line securement is 
due to the time 





discussed (not in 
detail) about the use 
of Dermabond for 
central lines, 
although emphasized 
that further data is 
needed to further 
analyze the risks and 
benefits of using 
Dermabond routinely 









ECMO CANNULA CARE BUNDLE  68 
 
   
 
Reference Purpose Sample, 
Setting 
Design, Framework Variables, methods for 
measurement 
Findings Implications Level of 
Evidence 
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(2019). Optimal 






works?  American 
Society for 
Artificial Internal 




























utilizing Coban for 
line securement to 
30-inch Hold-n-Place 
Leg band (intended 
for foley securement) 
as a headband. 
No statistics were measured 
in this article.  Writers 
shared that the Hold-n-place 
leg band was preferred 
method for IJ cannula 
securement.   
Hold-n-place leg band 
allowed for easier 
assessment of the skin 
around the head due to 
Velcro strap. 
 
Hold-n-Place leg band 
could be manipulated by 
the bedside nurse, where 
Coban required two sets of 
hands for proper 
placement and securement.   
 
Coban was requiring 
frequent replacement and 
patients would complain of 
headaches or discomfort 
related to the necessary 
tightness of the Coban 
placement. 
 
There was no statistical 
analysis on patient 











Leg band technique 
seems to be 
innovative way to 
anchor IJ cannula, 
but data based on 
patient experience, 
bedside provider 
experience and rates 
of dislodgement or 
migration before and 
after implementation 
of leg band would be 
helpful to guide 
practice 
VII 
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R., … Lucet, J.-C. 
(2012). Dressing 
disruption is a 





























changes at 3 
























This study’s research 
indicates that extending the 
scheduled dressing change 
to 7 days for a CVC 
decreases the risk for 
insertion site colonization 
for CVC’s. This study also 
indicated that the severity 
of organ failure for the 
patient directly correlated 
to an increase in dressing 
disruptions and increased 
risk for insertion site 
infections. 
The number of dressing 
disruptions is directly 
related to rate of skin 
colonization at insertion 
site (p= <0.013). 
Additional significant 
items in study are the 
greater the patient’s organ 
failure, according to the 
Sequential Organ Failure 
Assessment (SOFA), the 
greater the number of 
dressing interruptions (p= 
0.004). 
Authors indicated 
that they did not 
assess the risk for 
patient’s receiving 
renal replacement 
therapy and what 
role decreased renal 
function played 
within this study. 
Researchers alluded 
that increased fluid 
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Systematic review of 
22 RCT’s. 9 studies 
involved gauze with 
transparent dressings, 
6 compared CHG 
dressings for anti-












adhesive dressings to 
CHG impregnated 














Quality of evidence rated 
moderate for CHG 
impregnated dressings and 
the risk for CLABSIs (RR= 
0.65, CI= 0.40-1.05) and 
high from the studies of 
medication impregnated 
dressings. (RR= 0.60, CI= 
0.39-0.93). Two studies 
evaluated the quality of 
securement of CVCs and 
showed no difference in 
sutured compared to 
sutureless securement 
devices (RR= 1.20, CI= 
0.55-2.63) with a low level 
of evidence. 
This systematic review of 
research indicates that 
CHG and medication-
impregnated dressings 
lower the risk for 
CLABSIs, when compared 
to non-impregnated and 
gauze dressings with a 
moderate to high quality of 
evidence. 
This review is 
opposed to the Yu et 
al. study. 
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utilized data that had 
previously been 
collected by ELSO 
during this 
timeframe.  There 
was not a specified 
questionnaire 
generated for this 





















Neonate, pediatric and adult 
risk factors for infectious 
complications were 








and double lumen catheters.  
ECLS durations and pre-
ECLS cultures were also 
considered.   
Adult age population (OR 
1.02, p<0.001),  
longer duration of ECMO 
therapy (OR 1.09, p = 
0.002),  
positive pre-ECLS culture 
(OR 2.49, p<0.001),  
 are all associated with 
increased risk for 
infectious complications 
on ECLS.   
 
Infectious complications 
was associated with higher 
mortality for ECLS 
patients.   
 
10.2% of patient 
experienced an infectious 
complication on ECLS 
Traditional signs of 
infections are masked 
on a patient on 
ECLS, making it 
difficult to treat an 
infectious 
complication before 





imaging).   
 
Data is reported to 





complications.   
IV 
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e biguanide disc 
dressing to reduce 



















The purpose of 
this study was 




















Blinding was not 
possible, per the 
researchers, for this 
study. 
Single center study 
conducted in tertiary 
Australian hospital and not 
confined to the ICU setting.  
 
Inclusion criteria for this 
study includes: consenting 
patients admitted and 
requiring a PICC line for at 
least three days and no 
central line inserted during 
their admission. Dressing 
changes were scheduled for 
every 7 days 
There appear to be no 
difference in the amount 
of CLABSIs when 
comparing one anti-
microbial disc to another. 
There apparent 
differences seem to be in 
how patient’s skin reacts 
to the disc.  
 
Two confirmed CLABSIs 
reported by authors of this 
study, one in each disc 
group. Skin breakdown 
beneath the disc was 
reported in eleven patients 
with higher reported 
numbers in the PHMB 
group, than the CHG 
group (8 in PHMB and 3 
in the CHG groups). 
CHG discs appear to 
decrease the risk of 
skin breakdown for 
patients requiring a 
CVC, when 
compared to the 
alternative PHMB-
impregnated disc.  
II 
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(2018). Efficacy 
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infections in the 













The purpose of 
this study was 










of CLABSIs.  
The total 
sample size 
of this study 












study at a single 
hospital center in 
Hamburg, Germany 
from 2011 to 2012. 
In patients with new 
diagnoses of sepsis, 
researchers mandated that 2 
blood cultures be drawn 
from peripheral sites and 
the CVC explanted with tip 
sent for microbiological 
testing.  
 
CLABSI is defined by the 
researchers as positive 
microbiological cultures 
from the CVC tip and 
blood cultures. 
 
Sepsis is defined by the 
Surviving Sepsis Campaign 
guidelines.  
The study reported a 
decrease in the incidence 
of colonization in the 
checklist group when 
compared to the control 
group. 3.8 per 1000 
catheter days in the 
checklist group, compared 
to 5.9 per 1000 catheter 
days in the control group. 
(IRR= 0.57, p= 0.0001) 
 
This study suggests that 
the addition of a checklist 
lowers the incidence of 
CLABSIs in ICU patient 
populations by improving 
adherence to important 
steps in the dressing 
change process. 
More research is 
needed on the use of 
checklists to 
improve adherence 
given that this was a 
single research study 
at a single location. 
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blinding was not an 
option for this study. 
CLABSI rate is defined as 
the number of infections 
per 1000 catheter days. 
 
CVCs were randomly 
allocated to the 
intervention and control 
groups where subjects in 
control group received 
standard transparent 
dressings and subjects in 
the study group received a 
CHG-impregnated 
dressing.  
The study indicates that 
there is no statistical 
difference in CLABSI 
rates when using a CHG 
permeated transparent 
dressing instead of a non-
permeated transparent 
dressing. (X2= 0.028, p= 
0.868). 
This study has 
several significant 
limitations within 
their study, like 
length of the study, 
that it was only at a 
single hospital, with 
a limited sample 
size.  
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The Appraisal of Guidelines for Research & Evaluation Instrument (AGREE II) for the Clinical 
Practice Guideline for the Prevention of Intravascular Catheter-Related Infections 
Domain  Item  AGREE II Rating  










1. Scope and 
purpose  
   
1. The overall objective(s) of the 
guideline is (are) specifically 
described.      
Comments:   
This guideline reviews multiple evidence-
based strategies to decrease the risk for 
CLABSI 
 
The guideline’s objectives are clearly 
defined within this CPG. The guideline 
outlines these objectives and delivers 
rationales founded on evidence. 
                 
                 KG 
MA   
  2. The health question(s) covered by the 
guideline is (are) specifically described.  
Comments: 
Although the guideline does not outright 
list objectives as research questions for the 
guideline, the health questions are implied 
based on the evidence described. 
 
While I agree that the health questions are 
not explicitly stated, the purpose of the 
guideline is stated in the final paragraph of 
the introduction, and the CPG outlines 
various applications of preventing 
CLABSIs for both adult, pediatric, and 
neonate populations. 
   
               KG  MA 
  3. The population (patients, public, etc.) 
to whom the guideline is meant to apply 
is specifically described.  
Comment:  
The guideline visibly displays 
recommendations and strategies for 
                 
   
KG  
MA  
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CLABSI reduction adult, pediatric, and 
neonatal populations.  
 
The CPG outlines its recommendations for 
various patient populations that would 
benefit from CLABSI reduction strategies. 




4. The guideline development group 
includes individuals from all the relevant 
professional groups.  
Comment:   
Stakeholders are defined as the nursing 
staff, nurse educators that will partake in 
implementing protocols, patients with 
central venous lines (CVC), and healthcare 
systems. 
 
Stakeholders are clearly outlined within the 
CPG and defined as personnel involved in 
the insertion and maintenance of 
intravascular catheters. 
   
         
   
  
     
   
   
  KG 
MA   
  5. The views and preferences of the 
target population (patients, public, etc.) 
have been sought.  
Comment:  
Every category explained has background 
information to legitimize it’s use of 
recommendations with systematic reviews 
and meta-analyses.  
 
The authors expand on each category by 
including adult and pediatric/neonate 
section within the category and the 
implications for practice on each 
population. 
  
         
   
   
   
  
      
   
   
KG  
MA 
  6. The target users of the guideline are 




The guideline discusses any healthcare 
personnel trained in the management of 
invasive catheters can use this guideline 
with their clinical care. 
              MA 
  
 KG   
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The CPG loosely defines the personnel 
involved in the insertion and maintenance 
of the CVCs; that being said, this is a 
limited group of individuals. 
     
3.  Rigor of 
development  
7. Systematic methods were used to 
search for evidence.  
Comment:  
Research methods, databases used, and 
keywords searched were not described.  
Some information objectives had included 
a rationale for recommendations but did not 
include statistical evidence. 
 
No clear methodological evidence outside 
an unclear 5-point scale was used by the 
authors to show evidentiary quality.  
   
   MA KG       
   
  
 
   
   
   
  8. The criteria for selecting the evidence 
are clearly described.  
Comment:  
Each objective researched outlines a 
recommendation followed by a rationale 
for its recommendation. 
 
The criteria for selection and 
implementation are loosely provided by the 
authors by the summation of their reference 
materials. 
   
 
       MA KG   
  
   
  9. The strengths and limitations of the 
body of evidence are clearly described.  
Comment:  
The guideline does not explicitly state any 
limitations from the research 
performed.  Even though the material 
denoted in the recommendations and 
background rationale strengthens the 
choice to implement strategies, they are not 
explicit in stating strengths either.  
 
The evidentiary strengths are listed by way 
of a 5-point scale for recommending each 
section for an implementation. The 
limitations of this guideline are not listed. 
         MA    KG 
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  10. The methods for formulating the 
recommendations are clearly described.  
Comment:   
Even though they created a sound 
categorization for recommendations, there 
were no specific methods or criteria 
announced that needed to be met to include 
studies in the evidence behind 
interventions. 
 
The categorization of evidence is present, 
but the authors did not outline how their 
methods were founded. 
   
           KG  
MA   
   
  
  
   
  11. The health benefits, side effects, and 
risks have been considered in 
formulating the recommendations.  
Comment:  
The benefits, side effects, and risks have 
been well documented in the reasoning 
behind prevention interventions. 
 
The benefits of applying each article of the 
CPG are described and expanded upon with 
supporting evidence. 
  
              
   
  
   KG 
MA   
  12. There is an explicit link between the 
recommendations and the supporting 
evidence.  
Comment:  
The guideline states the list of 
recommendations, followed by rationale 
and background for each category of 
recommendations. 
 
There is a link between the 
recommendations and the evidence listed to 
support it. 
   
             
   
   
  
   KG 
MA   
  13. The guideline has been externally 
reviewed by experts prior to its 
publication.  
Comment:  
Several healthcare experts contributed to 
creating this guideline, and the CDC states 
                 KG  
MA 
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that external experts reviewed the guideline 
before publication. 
 
The contributing health experts to this CPG 
is extensive and extends into the nursing, 
medical, public health, and laboratory 
science professions to provide increased 
knowledge of the content at hand. 
  
  14. A procedure for updating the 
guideline is provided.  
Comment:   
Within the guideline, the original publish 
year was 2011, and there are multiple 
"notice to reader" flags to alert the reader 
that an update was done to the guideline 
most recently in 2017. 
 
Various areas within the CPG have been 
updated already, and it should be expected 
that more will follow. 
    
  
   
               KG 
MA   
4. Clarity of 
presentation  
15. The recommendations are specific 
and unambiguous.  
Comment:  
The recommendations are concrete in their 
detail in caring for the insertion site of the 
catheter and patient that has received the 
line. 
 
The recommendations are specific and 
detailed in their description of evidence 
within the CPG to outline what is or should 
be, best practice for decreasing the rates of 
CLABSI. 
  
              
   
   
   
  
  
   
KG 
MA 
  16. The different options for 
management of the condition or health 
issue are clearly presented.  
Comment:   
There are a variety of recommendations 
that are tailored to various styles and 
locations of CVCs 
 
I would argue that this guideline is better 
suited to prevent health issues when 
             
   
 KG MA 
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applied as best practice. Given that this is 
not a guideline used for the treatment of 
disease-states, instead, it is used to prevent 
disease-states from occurring. 
  
  17. Key recommendations are easily 
identifiable.  
Comment:  
Recommendations are easily identified by 
category throughout the guideline.  
 
Key recommendations are easily 
recognizable throughout the CPG.  
              
   
   
   
   KG 
MA   
5. 
Applicability  
18. The guideline describes facilitators 
and barriers to its application.  
Comment:  
Recommendations for each possible 
intervention provide direction for the 
reader to analyze barriers within their 
facility.  The writers of the guideline 
discuss the need for ongoing education on 
CLABSI prevention. 
 
Barriers and facilitators to the application, 
while not explicitly stated, can be inferred 
upon by reading the individual sections and 
establishing a facility-wide trajectory for 
implementation to discover what may 
hinder or make way for facility change. 
  
   
   
  
   
   
   






  19. The guideline provides advice and/or 
tools on how the recommendations can 
be put into practice.  
Comment:  
The guideline thoroughly explains the steps 
and interventions required at each step of 
dressing change and CVC insertion as well 
as provides background for 
recommendations. 
 
The CPG explains and recommends how to 
implement these guidelines into practice in 
a descriptive manner. 
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  20. The potential resource implications 
of applying the recommendations have 
been considered.  
Comment:  
The resources that are recommended are 
identified in the interventions that are 
suggested to be implemented. 
 
While some of the recommendations 
provide a cost analysis for implementing 
these measures into practice, overall, this is 
not discussed in the CPG. The authors, 
however, have described a step as "more 
expensive," like when talking about 
CHG/silver-impregnated CVCs. 
  
   
   
  
  
   
   
   
 
MA   
 
KG 
  21. The guideline presents monitoring 
and/ or auditing criteria.  
Comment:   
The guideline has a specific section 
devoted to performance improvement. 
Within this section, the authors supply a list 
of specific interventions necessary to 
monitor for and prevent the incidence of 
CRBSI.  
 
The CPG provides auditing criteria for 
facilities to use for quality improvement 
measures.  
  
      
  







22. The views of the funding body have 
not influenced the content of the 
guideline.  
Comment:  
A systematic review was performed to 
address any issues that were notable or 
mentioned before publication. 
 
The authors list any disclosures of CoI in 
the acknowledgment section of the CPG 
and disclose that an independent firm 
provided this analysis to maintain 
independence. 
  
   
   
   
   
   
   
   
   
   
   
  
        KG MA 
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  23. Competing interests of guideline 
development group members have been 
recorded and addressed.  
Comment:  
Within the acknowledgment section, there 
is a disclosure of potential conflicts and 
interests, including a list of organizations 
and individuals who participated in certain 
parts of the guideline (i.e., funding, etc.). 
 
The authors list the disclosures CoI in the 
acknowledgment section of the CPG. 
Within it are various entities that may have 
an impact on the impartiality of this work. 
   
  









1. Rate the overall quality of this 
guideline.  
   
   







2  3  4  5  6  
KG 
MA 








  2. I would recommend this guideline for 
use.  
Notes:  
I recommend these guidelines but would 
like to see an in-depth systematic review of 
evidence that displays and strengthens the 
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Appendix E 
AGREE II Scoresheet 
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Appendix F 
Critical Appraisal of Systematic Review – CVC Dressings and Securement 
 
Article Reviewed: Ullman, A. J., Cooke, M. L., Mitchell, M., Lin, F, New, K., Long, D. 
A., Mihala, G., & Rickard, C. M. (2019). Dressings and securement devices for central venous 
catheters (CVC). Cochrane Database of Systematic Reviews (9). Doi: 
10.1002/14651858.CD010367.pub2.  
Research Question 
Does the review address a clearly 
defined issue? 
Yes – there are several dressing and securement products 
available for central lines, but it is not known which 







Yes – RCTs analyzing short- and long-term CVCs, 
tunneled and non-tunneled, porta-a-caths, hemodialysis 
lines, and peripherally inserted central catheters.  The 




Yes – includes chlorhexidine impregnated dressings, 
standard polyurethane dressings, silver-impregnated 




Yes – to compare the available dressings and securement 
devices for CVCs to identify which work best.   
Is the review question clearly and 
explicitly stated? 
Yes – “The objective of this research was to compare the 
available dressings and securement devices for CVC’s to 
identify what works best” (p. 2, 2019). 
 
Literature Review 
Were comprehensive search 
methods used to locate studies? 
Yes – reviewers used electronic databases from eight 
different sources and used 21 different combinations of 
keywords in searches. 
Was a thorough search of 
appropriate databases done? 
Yes – in addition to a thorough review of electronic 
databases, the researchers also searched for clinical trials 
related to CVC dressings by looking at seven different 
databases. 
Were other potentially important 
databases observed? 
Yes – the researchers stated they hand-searched 
bibliographies of all retrieved and relevant publications 
for further relevant studies. 
Were the search methods 
thoroughly described? 
Yes – Search methods and identification of studies were 
very thoroughly discussed and described.  
Were conclusions drawn about 
the possible impact of publication 
bias? 
Yes – publication bias was assessed by teams of two 
review authors, and data were cross-checked for accuracy 
and agreement. 
Were the overall findings 
assessed for their robustness in 
Yes – writers offer transparency in the rationale for 
inclusion and exclusion of articles reviewed. 
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Were inclusion criteria for 
selecting studies clearly described 
and fairly applied? 
Yes – two authors independently reviewed and retrieved 
studies for relevance.  The full versions of all articles 
were reviewed by both reviewers and independently 
selected for inclusion.  Articles that both reviewers agreed 
on were included, articles with discrepancies were 
discussed between the reviewers with the consultation of 
a third party to eliminate bias.  
 
Critical Appraisal 
Was study quality assessed by 
blinded or independent raters? 
Yes – Quality was assessed by independent raters using 
the Grading of Recommendations Assessment, 
Development, and Education approach (GRADE) 
Was the validity of included studies 
assessed? 
No – this was not explicitly discussed. 
Was the validity of studies assessed 
appropriately? 
No – this was not explicitly discussed. 
Are the validity criteria reported? No – this was not explicitly discussed. 
 
Similarity of Groups and Treatments 
Were reasons given for any 
differences between individual 
studies explored? 
Yes – the reviewers assess heterogeneity of the 
compared studies before meta-analysis 
Are treatments similar enough to 
combine? 
Yes – researchers included several different types of 
dressing for CVCs, and outcomes were measured in 
CLABSI occurrences following the intervention. 
Do the included studies seem to 
indicate similar effects? 
Yes – the dressing chosen for each study was analyzed 
by the effect on CLABSI.  The writers provide clear 
criteria for what would be considered a positive 
CLABSI.   
If not, was the heterogeneity of effect 




Were the findings from individual 
studies combined appropriately? 
Yes – although this meta-analysis provides a wide 
variety of CVC dressing options. 
Are the methods used to combine 
studies reported? 
Yes – since there are multiple dressing options 
available, the reviewers used a Multiple Treatments 
Meta-analysis (MTM) 
Was the range of likely effect sizes 
presented? 
Yes – effect sizes were reported for each article 
reviewed 
Were null findings interpreted 
carefully? 
Null findings were not discussed, the article did not 
explicitly state methods for reviewing null findings 
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Were the methods documented? Yes – methods were adequately explained. 
Are review methods clearly reported? Yes 
 
Summary of Findings 
Is a summary of findings provided? Yes 
Are specific directives for new 
research proposed? 
Yes – suggested that researchers plan protocol to reduce 
risk of bias, and clearly report trials and implementation 
methods in research. 
Are the recommendations based 
firmly on the quality of the evidence 
presented? 
“There was inadequate research to permit us to make 
recommendations about CVC security using the 
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Appendix G 
Critical Appraisal of Systematic Review – CVC Location Related to Risk for Infection 
 
Article Reviewed: Marik, P. E., Flemmer, M., & Harrison, W. (2012). The risk of catheter-
related bloodstream infection with femoral venous catheters as compared to subclavian and 
internal jugular venous catheters. Critical Care Medicine, 40(8), 2479–2485. doi: 
10.1097/ccm.0b013e318255d9bc 
Research Question 
Does the review address a clearly defined 
issue? 
Yes – the article researches whether CVCs 
inserted in the femoral vein have a higher risk 
for CRBIs than CVCs inserted in the internal 





The population studied Yes – the review specifies that adult patients 
were participating in RCTs and cohort studies 
between the years of 1966 to 2011 all patients 
received non-tunneled CVCs as a method of 
treatment during their hospitalization. 
The intervention and/or 
treatment given 
Yes – CVCs were inserted in the two RCTs 
documented in the systematic review. Both 
RCTs are French studies that documented the 
difference in CRBIs between subclavian and 
femoral CVC insertions and internal jugular and 
femoral CVC insertions.  
The outcome(s) considered Yes – consideration for the differences in 
CRBIs depending on whether the CVC was 
inserted into the subclavian, femoral, or internal 
jugular vein.  
Is the review question clearly and explicitly 
stated? 
Yes – The review question was explicitly 
stated, “to determine the risk of catheter-related 
bloodstream infections related to non-tunneled 
central venous catheters inserted at the femoral 




Were comprehensive search methods used to 
locate studies? 
Questionable – Medline and Google were 
used with nine different subject headings and 
keywords. The authors stated that Google was 
utilized to search for results in non-peer-
reviewed journals. 
Was a thorough search of appropriate 
databases done? 
Yes – The authors used EMBASE, and 
Cochrane Review databases were included in 
their review of data. 
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Were other potentially important databases 
observed? 
Yes – The authors reviewed the 
bibliographies of all articles obtained until no 
new articles could be found for review. 
Were the search methods thoroughly 
described? 
Yes – the article discusses in detail the 
process for search and selection of articles for 
data retrieval. 
Were conclusions drawn about the possible 
impact of publication bias? 
Yes – the reviewers compiled the articles into 
a funnel plot to assess for publication bias and 
found some degree of publication bias within 
the articles selected in the review. 
Were the overall findings assessed for their 
robustness in terms of the selective inclusion 
or exclusion criteria? 
Yes – The authors discuss in detail their 
process for selecting articles based on the 




Were inclusion criteria for selecting studies 
clearly described and fairly applied? 
Yes – Two authors gathered data from 
relevant studies based on a standardized form, 
and data was retrieved based on study design, 
size, setting, patient population, number of 
catheters at each insertion site, number of 
catheter days, number of CRBIs, and 
frequency of DVTs reported. 
 
Critical Appraisal 
Was study quality assessed by blinded or 
independent raters? 
No – There was no indication made in the 
review that the study quality was blinded or 
assessed by independent raters. 
Was the validity of included studies assessed? Questionable – While inclusion tables were 
included outlining the inclusion and exclusion 
criteria for final inclusion and the review 
outlines how the two authors independently 
reviewed for inclusion criteria, there was no 
expansion to digital academic search engines 
outside and databases of Medline, EMBASE, 
and Cochrane Review. 
Was the validity of studies assessed 
appropriately? 
No – Expansion on the validity of the study's 
appropriateness was not mentioned. 
Are the validity criteria reported? Yes – The criteria mentioned to assess for 
validity are mentioned by the authors in the 
Study Selection and Data Extraction section. 
Similarity of Groups and Treatments 
Were reasons given for any differences 
between individual studies explored? 
Yes – Heterogeneity was assessed for the 
studies chosen in the review. Two outliers 
were identified that, when removed, also 
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eliminated the heterogeneity within the 
review. 
Are treatments similar enough to combine? Yes – Once the two studies were identified, 
the treatment appeared similar enough to 
combine. 
Do the included studies seem to indicate 
similar effects? 
Yes – The included studies indicate a similar 
effect.  
If not, was the heterogeneity of effect 
assessed and discussed? 
Yes – Two included studies contributed to the 
heterogeneity of the studies within the review. 
Once identified, the authors note that 
heterogeneity was removed. 
 
Data Synthesis 
Were the findings from individual studies 
combined appropriately? 
Yes – findings were combined appropriately 
and according to study type (cohort and 
RCT). It should be noted that the authors 
discovered that the age of study impacted the 
rate of CRBI prevalence and that the 
incidence decreased over time.  
Are the methods used to combine studies 
reported? 
Yes – The methods that the authors used for 
combining the studies were reported in detail. 
Was the range of likely effect sizes presented? Yes – the ranges of effect sizes are detailed 
within the review. 
Were null findings interpreted carefully? No – Null findings were not mentioned in the 
review. 
Were the methods documented? Yes – The methods were documented within 
the review. 
Are review methods clearly reported? Yes – The review clearly reports the findings 
of the articles reviewed with findings reported 
clearly and abundantly. 
 
Summary of Findings 
Is a summary of findings provided? Yes – A summary of findings is provided. 
Are specific directives for new research 
proposed? 
No – The authors do not propose that further 
research is needed to corroborate their review 
and recommend that femoral-insertion of 
CVCs are a safe alternative to subclavian and 
internal jugular vein CVCs. 
Are the recommendations based firmly on the 
quality of the evidence presented? 
Yes – The recommendation that the usage of 
femoral-inserted CVCs is a safe alternative is 
based firmly on the quality of evidence 
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Appendix H 
Cost Analysis for ECMO Cannula Site Care Bundle 
 
Product – current practice Cost 
Central line dressing kit: 
• 4x4 Tegaderm (3M) 
• Cavilon swab (3M) 
• Chlorhexidine stick (Prevantics) 
• 3-line caps 
• Sterile drape (3M) 
• 2x2 gauze (Covidien) 
• 4x4 gauze (Covidien) 
• Biopatch CHG-impregnated disc 
• Sterile gloves 
• Surgical mask (3M) 
 
• $ 0.48** 
• $ 0.75** 
• $ 1.70  
• $ 6.72 
• $ 0.99** 
• $ 0.04 
• $ 0.10 
• $ 5.99 
• $ 1.43 
• $ 0.24** 
Chlorhexidine swab (Prevantics) $ 1.70  
4x10 Tegaderm (3M) $ 1.073** 
Stat-lock w/ tie down (Maquet) $ 6.00 
Hollister vertical tube attachment (Optional) $ 9.99 
TOTAL  $27.21 with Maquet anchor  
$31.20 with Hollister anchor 
 
 
Product – desired practice OPTION 3 Cost 
4X6 Tegaderm with CHG (3M) $ 5.96** 
2 Chlorhexidine sticks (Prevantics) $ 3.40  
Cavilon swab (3M) need 2 $ 0.75** 
Bioderm CathGrip Securement Device $ 9.96** 
4x4 gauze (Covidien) $ 0.10 
Sterile drape $ 0.99 
Sterile gloves $ 1.43 
Surgical mask (3M) $ 0.24** 
TOTAL $ 23.58 
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Johns Hopkins Model Implementation Plan for ECMO Cannula Site Bundle 
 
 
Step 3: Develop and refine the EBP question  
Step 4: Identify stakeholders  
Step 5: Determine responsibility for project leadership  
Step 6: Schedule team meetings  
  
EVIDENCE  
Step 7: Conduct internal and external search for evidence  
Step 8: Appraise the level and quality of each piece of evidence  
 Step 9: Summarize the individual evidence  
Step 10: Synthesize overall strength and quality of evidence  
Step 11: Develop recommendations for change based on evidence synthesis  
• Strong, compelling evidence, consistent results   
• Good evidence, consistent results  
• Good evidence, conflicting results   
• Insufficient or absent evidence  
  
TRANSLATION   
Step 12: Determine fit, feasibility, and appropriateness of recommendation(s) for 
translation path  
Step 13: Create action plan  




PET Management Guide     
PRACTICE QUESTION  
Step 1: Recruit interprofessional team  
Step 2: Define the problem  
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Step 15: Implement action plan  
Step 16: Evaluate outcomes  
Step 17: Report outcomes to stakeholders   
Step 18: Identify next steps  
Step 19: Disseminate findings 
© 2017 The Johns Hopkins Hospital/ Johns Hopkins University School of Nursing  
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Appendix J 
Checklist for Cannula Site Care Protocol 
For all peripherally inserted ECMO Cannulas (RIJ and Femoral) 
 
 
Dressing Change Timing: 
 
ECMO Cannula Insertion sites should be changed: 
• Every 7 days 
• Every 2 days if gauze or hemostatic dressing is in place 






Please ensure you have the following supplies: 
 
❑ Central line dressing kit 
❑ BioDerm Cath Grip  
❑ 4”x 6” CHG impregnated Tegaderm 
❑ IF TWO CANNULAS IN SAME 
SITE - 1 Prevantics swabstick 
❑ 1 Cavilon barrier film 




❑ 1 Cavilon barrier film 

















***PLEASE return this completed form to Kelly Garaffa’s mailbox for ALL 
peripheral ECMO dressing changes from [DATE] to [DATE]*** 
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❑ Obtain an “ECMO Cannula Site Care Kit” from supply room and ensure products listed 
above are present. 
❑ Disinfect workspace with Chlorhexidine. (I.e. bedside table or counter space) 
❑ Perform hand hygiene, open the first portion of the central line kit, which is non-sterile. 
❑ Don mask and clean gloves. 
❑ Assess if clipping/hair removal is indicated – if so, pull back dressing keeping insertion 
site covered by at least 2.5cm radius.  Clip any hair that has grown as necessary. 
❑ Carefully remove soiled or outdated dressing without contaminating the area under the 
dressing. 
❑ Visually inspect insertion site for redness, drainage, swelling, or signs of infection.   
❑ Inspect insertion site stitch, if stitch is no longer intact – notify attending physician 
immediately. 
❑ Doff clean gloves, perform hand hygiene, and don new pair of clean gloves. 
❑ Clean insertion site and surrounding skin (an area approximately the size of the dressing) 
with Prevantics swabstick.  Place one flat side of the foam tip to the skin and prep the 
skin in vigorous back-and-forth repeated strokes for 1 minute.  Turn the swabstick over 
(unused side of the foam tip) and repeat procedure by prepping for 1 minute.  Allow the 
prepped area time to dry for 1 minute.  Do not blot, fan, or wipe dry. If there are two 
cannulas at same insertion site, do not use the same Prevantics.  Repeat this step 
with a new Prevantics over next site. 
❑ Remove gloves and perform hand hygiene. 
❑ Open sterile portion of the kit on a clean, flat surface.  Sterilely drop the 4” X 6” CHG 
impregnated Tegaderm onto the field. 
❑ Don sterile gloves. 
❑ Apply Cavilon skin protectant around insertion site, do not get closer than 4cm around 
insertion site.  Allow 30 seconds to dry. 
❑ Apply CHG impregnated Tegaderm over site making certain the edges are smooth and 
adherent to the patient. 
❑ Label the dressing with date/time/initials: 
▪ *FEMORAL CANNULA* 9-12 inches away from insertion site, swab barrier film, once 
dry place anchor on thigh. 
▪ *IJ CANNULA* below patient’s opposite collarbone swab barrier film, once dry place 
anchor. 
❑ Document in ECMO flowsheet the dressing change, reason for dressing change, insertion 
site assessment and all interventions completed. 
 
 
Performed by: _________________________________________________  
Date:_________________ 
 
Patient sticker:  
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(This is a draft of what will be generated utilizing survey monkey) 
 
How many years of experience do you have? 
 [Fill in the blank] 
 
How many years of ECMO experience do you have? 
[Fill in the blank] 
 
Which of the following is true about the ECMO Cannula Site Care bundle? 
The ECMO Cannula Site Care Bundle simplified the dressing change process 
It made my workflow more difficult 
It did not change my workflow 
It improved my workflow easier 
 
Which of the following is true about the BioDerm CathGrip anchor? 
The BioDerm anchor prevent movement of the cannula more adequately than previous 
methods 
The BioDerm anchor provides the same amount of support as previous anchoring 
methods 
The BioDerm anchor provides less support than previous anchoring methods 
 
Which of the following is true regarding the CHG impregnated dressing? 
The CHG dressing provides adequate cannula coverage, not requiring reinforcement 
The CHG dressing is does not adequately cover the dressing, requiring the use of 
additional dressings 
The CHG dressing provides the same coverage as the tegaderm used previously.  
 
Which of the following are true when comparing the CHG coverage in the dressing compared to 
the biopatch? 
The CHG segment has better contact to the insertion site compared to the biopatch 
The CHG segment does not make adequate contact to the insertion site, the biopatch is a 
better product for the ECMO patient. 
The CHG segment provides the same contact to the insertion site compare to the biopatch 
 
Which of the following is true regarding skin integrity with the new dressing method. 
There was more skin breakdown related to the new dressing practice 
There was less skin breakdown related to the new dressing practice 
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The ECMO cannula site care bundle provides adequate supplies for sterilely cleaning the cannula 





Which of the following are the most common reasons for changing an ECMO cannula site 
dressing? (Select all that apply) 
Bloody/saturated 
Dressing not intact 
Dressing lasted 7 days, requiring change 
The dressing was removed for a procedure (ex. Cannula advancement, replacing sutures, 
etc.) 
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Peripheral ECMO Preliminary Confounding Data  
  
TIMELINE: June 1, 2019 – June 1, 2020  
  
Patient populations: All peripheral ECMO patients with the following cannulation sites:  
• Right internal jugular vein  
• Right femoral vein  
• Right femoral artery  
• Left femoral vein  
• Left femoral artery  
Exclude all patients that have any central cannulation sites (i.e. open chest, left ventricular vent)  
  
ECMO site flowsheet data:   
• Number of days on ECMO, number of hours  
• Number of times there was a “circuit change”  
• Number of dressing changes  
• Reason for dressing change (saturated, not intact)  
• Veno-Veno (2 venous insertion sites) or Veno arterial (1 venous, 1 arterial 
insertion site)  
  
Location that patient was cannulated:  
• OR 
• CV Lab 
• Bedside  
• Outside hospital 
  
Patient data:  
• Age  
• Gender  
• Admitting diagnosis (unsure if able to get this, or need to chart review?)  
• Number of vent days before cannulation  
• APACHE Score – unknown if we track this?  
• Survival to discharge?  
  
Infection control data:  
• Positive blood cultures during ECMO therapy  
o Include 48 hours after ECMO is discontinued  
o Include 48 hours after ECMO is initiated  
• Positive CLABSI during ECMO therapy and 48 hours after  
• If positive blood cultures during ECMO therapy, what was the organism?  
Sentinel events:  
• Cannula dislodgement  
  
 
